<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>MedWorm: Dialysis</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 7000 RSS medical sources are combined and output via different filters. This feed contains the latest news and research in the Dialysis category.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=dialysis+hemodialysis+haemodialysis+hemofiltration+haemofiltration+hemodiafiltration+haemodiafiltration&kid=156597&t=Dialysis&f=p]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 03:45:08 +0100</lastBuildDate>
        <item>
            <title>AngioDynamics Launches DuraFlow(TM) 2 Chronic Hemodialysis Catheter</title>
            <link>http://www.medworm.com/index.php?rid=5669383&amp;cid=c_156597_34_f&amp;fid=23304&amp;url=http%3A%2F%2Fwww.globenewswire.com%2F%2Fnewsroom%2Fnews.html%3Fref%3Drss%26d%3D245199</link>
            <description>ALBANY, N.Y., Feb. 8, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, has announced the U.S. launch of the next generation DuraFlow(tm) 2 chronic hemodialysis catheter and the upcoming launch of the DuraFlow(tm) 2 VascPak(r) (VP) kit. (Source: Medical News (via PRIMEZONE))&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Medical News (via PRIMEZONE)</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5669383</comments>
            <pubDate>Wed, 08 Feb 2012 11:30:00 +0100</pubDate>
            <guid isPermaLink="false">5669383</guid>        </item>
        <item>
            <title>GLIVEC Tablets (imatinib)- Revised SPC</title>
            <link>http://www.medworm.com/index.php?rid=5667569&amp;cid=c_156597_13_f&amp;fid=38895&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FOther-Lib-Updates%2FSPC-Changes%2FGLIVEC-Tablets-imatinib--Revised-SPC%2F</link>
            <description>Source: eMC (electronic Medicines Compendium)
Area: Other Library Updates &amp;#62; SPC Changes
  There have been significant updates to several sections of the SPC, including the following:   
  &amp;#160;  
  Change to section 4.2 - Posology and method of administration    
   &amp;#160;   
  Patients  with renal dysfunction  or on dialysis  should be given the minimum recommended dose of 400&amp;#160;mg daily as starting dose.  However, in these patients caution is recommended. The dose can be reduced if not tolerated. If tolerated, the dose can be increased for lack of efficacy (see sections 4.4 and 5.2).   
  &amp;#160;  
  Change to section 4.4 - Special warnings and precautions for Use    
   &amp;#160;   
  When Glivec is co-administered with other medicinal products, there is a potential for drug interac...</description>
            <author>NeLM - SPC Changes</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667569</comments>
            <pubDate>Wed, 08 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5667569</guid>        </item>
        <item>
            <title>Clinical Performance and Skill Retention after Simulation‐based Education for Nephrology Fellows</title>
            <link>http://www.medworm.com/index.php?rid=5668096&amp;cid=c_156597_19_f&amp;fid=29470&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1525-139X.2011.01018.x</link>
            <description>AbstractWe previously demonstrated that simulation‐based education (SBE) improved temporary hemodialysis catheter (THDC) insertion skills by nephrology fellows. SBE, featuring deliberate practice and rigorous achievement standards, was a powerful method to enhance THDC insertion skills in nephrology fellows. However, experts have called for further research to evaluate skill transfer from the simulated environment to actual clinical care and skill retention. This is a prospective observational cohort study of THDC insertion skills. Twelve nephrology fellows from three academic centers in Chicago were evaluated using a skills checklist from July 2008 to June 2009. Simulator‐trained fellows were tested after the SBE intervention and expected to meet or exceed a minimum passing score (MPS...</description>
            <author>Seminars In Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668096</comments>
            <pubDate>Tue, 07 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5668096</guid>        </item>
        <item>
            <title>The use of an artificial skin model to study transdermal absorption of drugs in inflamed skin.</title>
            <link>http://www.medworm.com/index.php?rid=5664162&amp;cid=c_156597_13_f&amp;fid=32516&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22293350%26dopt%3DAbstract</link>
            <description>Authors: Oshima S, Suzuki C, Yajima R, Egawa Y, Hosoya O, Juni K, Seki T
    Abstract
    Studies on drug disposition in inflamed skin are important for safe and effective application of topical drugs. Here, the absorption of flurbiprofen (FP) through inflamed skin was examined in vivo and in a skin-mimicking artificial model system. The model skin system consisted of a silicone membrane acting as a model stratum corneum, laminated dialysis membranes acting as a model of viable skin, and 2 microdialysis probes-one used for determination of FP concentration and one acting as a model vessel. This model system could be used for quantitative evaluation of complicated permeation processes. In the in vivo experiments, FP absorption was suppressed in rats with inflamed skin induced by an intracut...</description>
            <author>Biological and Pharmaceutical Bulletin</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664162</comments>
            <pubDate>Mon, 06 Feb 2012 19:48:04 +0100</pubDate>
            <guid isPermaLink="false">5664162</guid>        </item>
        <item>
            <title>Home-based Dialysis For Kidney Failure Gaining Popularity In Developing Countries</title>
            <link>http://www.medworm.com/index.php?rid=5662691&amp;cid=c_156597_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FHPA6WtOGdqo%2F241140.php</link>
            <description>Home-based dialysis treatments are on the rise in both the developing and developed worlds, but developed countries appear to be turning to them less often, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The findings, which provide a global snapshot of dialysis use among patients with kidney failure, may impact future business and research innovations. Dialysis treatments for kidney failure come in two forms: peritoneal dialysis is usually done at home, while hemodialysis is predominantly clinic-based... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5662691</comments>
            <pubDate>Mon, 06 Feb 2012 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">5662691</guid>        </item>
        <item>
            <title>Blood Pressure Measurements and Left Ventricular Mass Index in Hemodialysis Patients</title>
            <link>http://www.medworm.com/index.php?rid=5664394&amp;cid=c_156597_73_f&amp;fid=22304&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1525-1594.2011.01401.x</link>
            <description>AbstractLeft ventricular hypertrophy (LVH) is the most frequent cardiac abnormality in hemodialysis (HD) patients. It is related to cardiovascular diseases and is an important risk factor for mortality in HD patients. Arterial hypertension is an established risk factor for LVH in HD patients. Inferior vena cava (IVC) diameter is a good indicator of circulating fluid volume; hypervolemia is an important pathogenetic factor of hypertension in HD patients. The purpose of our study was to evaluate possible association between LVH, IVC diameter, and different blood pressure (BP) measurements in HD patients. In the present study, 85 HD patients were included. BP was measured with a standard mercury sphygmomanometer before and after the HD session; the average 1‐monthly values of the routine BP...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Artificial Organs</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5664394</comments>
            <pubDate>Mon, 06 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5664394</guid>        </item>
        <item>
            <title>Iron therapy in patients with chronic kidney disease</title>
            <link>http://www.medworm.com/index.php?rid=5668146&amp;cid=c_156597_19_f&amp;fid=38758&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1778-428X.2012.01156.x</link>
            <description>SUMMARYIron deficiency, both functional and absolute, is common in patients with chronic kidney disease and in those requiring dialysis. The Renal National Service Framework and National Institute for Health and Clinical Excellence advocate treatment of anemia in patients with chronic kidney disease. Oral iron is often both insufficient and slow to improve hemoglobin levels while intravenous supplementation replenishes and maintains iron stores more effectively. This leads to a reduction in the use of erythropoietin stimulating agents. This reduction in erythropoietin stimulating agents use may be potentially beneficial in certain cases in particularly reducing stroke risk. In contrast, intravenous iron has the potential to improve quality of life, reduce cardiovascular risk and produce co...</description>
            <author>Transfusion Alternatives in Transfusion Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668146</comments>
            <pubDate>Sun, 05 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5668146</guid>        </item>
        <item>
            <title>For Kidney Disease Patients, Goals For Blood Pressure May Be Unrealistic</title>
            <link>http://www.medworm.com/index.php?rid=5657638&amp;cid=c_156597_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FNtTFsNqQAuk%2F241125.php</link>
            <description>An upward revision of the blood pressure numbers used to identify risk of end-stage renal disease (ESRD) might actually help doctors provide better care for their patients, said the authors of a study in patients with chronic kidney disease (CKD). The researchers found that systolic blood pressure - the &quot;upper number&quot; in a blood pressure reading - was the key variable. Current guidelines call for CKD patients to maintain a systolic pressure of 130/80 or lower in order to prevent ESRD, which is complete or almost complete kidney failure, leading to dialysis, kidney transplant, or death... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5657638</comments>
            <pubDate>Sat, 04 Feb 2012 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">5657638</guid>        </item>
        <item>
            <title>More home dialysis in developing countries</title>
            <link>http://www.medworm.com/index.php?rid=5657438&amp;cid=c_156597_26_f&amp;fid=37864&amp;url=http%3A%2F%2Fpheed.upi.com%2Fclick.phdo%3Fi%3D69fc113546f7f7659c4beaa52ca7675a</link>
            <description>LONDON, Ontario, Feb. 3 (UPI) -- Use of home-based dialysis is increasing in developing and developed nations, but more so in developing countries, Canadian researchers said. (Source: Health News - UPI.com)</description>
            <author>Health News - UPI.com</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5657438</comments>
            <pubDate>Sat, 04 Feb 2012 04:33:58 +0100</pubDate>
            <guid isPermaLink="false">5657438</guid>        </item>
        <item>
            <title>A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free
liver dialysis by the Molecular Adsorbents Recirculating System</title>
            <link>http://www.medworm.com/index.php?rid=5654905&amp;cid=c_156597_53_f&amp;fid=28800&amp;url=http%3A%2F%2Fccforum.com%2Fcontent%2F16%2F1%2FR20</link>
            <description>IntroductionThe Molecular Adsorbent Recycling System (MARS) is used to treat patients with liver failure. Observational data suggest that citrate anticoagulation during MARS is feasible. Comparative studies on the optimal anticoagulation regimen during MARS are lacking. The aim of the current study was to evaluate two heparin-free anticoagulation regimens.
Methods:
We performed a prospective randomized open-label crossover study of regional citrate anticoagulation against no anticoagulation. Ten patients (age 55 +/- 11 years) with liver failure undergoing MARS treatment were included. The primary endpoint was completion of MARS sessions. Secondary endpoints included treatment efficacy and safety. Longevity of MARS treatment was plotted as a Kaplan-Meier estimate. Fisher's exact test was us...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Critical Care</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654905</comments>
            <pubDate>Fri, 03 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5654905</guid>        </item>
        <item>
            <title>Necrotizing fasciitis of thigh associated with EscherichiaColi bacteremia in a patient on chronic hemodialysis</title>
            <link>http://www.medworm.com/index.php?rid=5660567&amp;cid=c_156597_19_f&amp;fid=29463&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1542-4758.2011.00658.x</link>
            <description>We present a 59‐year‐old male on chronic hemodialysis (HD). We made the diagnosis of necrotizing fasciitis of the right thigh due to the crepitus from physical examination and subcutaneous emphysema from an X film. He was successfully treated with antibiotics and surgical debridement. The blood and surgical drainage cultures showed Escherichia coli, which is less commonly seen in cutaneous infection. The colonoscopic finding revealed adenomatous polyps. Necrotizing fasciitis in patients on HD requires early diagnosis and aggressive treatment to ensure the favorable clinical outcomes. (Source: Hemodialysis International)</description>
            <author>Hemodialysis International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660567</comments>
            <pubDate>Fri, 03 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5660567</guid>        </item>
        <item>
            <title>Caregiver burden among nocturnal home hemodialysis patients</title>
            <link>http://www.medworm.com/index.php?rid=5660568&amp;cid=c_156597_19_f&amp;fid=29463&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1542-4758.2011.00657.x</link>
            <description>AbstractRecent studies have suggested improvements in quality of life (QOL) in patients on quotidian dialysis compared with conventional hemodialysis. Few studies have focused on the burden and QOL in caregivers of patients with end‐stage renal disease (ESRD) on nocturnal home hemodialysis (NHD). We aim to assess the caregivers’ burden, QOL, and depressive symptoms and to compare these parameters with their patients’ counterparts. Cross‐sectional surveys were sent to 61 prevalent NHD patients and their caregivers. Surveys assessed demographics, general self‐perceived health using the 12‐Item Short Form Health Survey (SF‐12) and the presence of depression using the Beck Depression Inventory. Subjective burden on caregivers was assessed by the Caregiver Burden scale and was com...</description>
            <author>Hemodialysis International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660568</comments>
            <pubDate>Fri, 03 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5660568</guid>        </item>
        <item>
            <title>Risk Factors Associated with Coronary Artery Calcification Should Be Examined before Kidney Transplantation.</title>
            <link>http://www.medworm.com/index.php?rid=5648084&amp;cid=c_156597_39_f&amp;fid=36115&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22293651%26dopt%3DAbstract</link>
            <description>In conclusion, the examination and prevention of risk factors associated with atherosclerosis should be started at the beginning of renal failure.
    PMID: 22293651 [PubMed - in process] (Source: The Tohoku Journal of Experimental Medicine)</description>
            <author>The Tohoku Journal of Experimental Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648084</comments>
            <pubDate>Thu, 02 Feb 2012 18:24:02 +0100</pubDate>
            <guid isPermaLink="false">5648084</guid>        </item>
        <item>
            <title>Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center</title>
            <link>http://www.medworm.com/index.php?rid=5663187&amp;cid=c_156597_47_f&amp;fid=33391&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb327573126878p13%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The current clinical characteristics and outcome suggest a greater severity of peritonitis episodes and higher risk of death,
 possibly due to bacterial resistance. Older age is a risk factor for death.
 
 
 
 
	Content Type Journal ArticleCategory Nephrology – Original PaperPages 1-9DOI 10.1007/s11255-011-0107-7Authors
		Luiz Gustavo Oliveira, Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University-UNESP, Botucatu, Sao Paulo 18618-970, BrazilJuliana Luengo, Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University-UNESP, Botucatu, Sao Paulo 18618-970, BrazilJacqueline C. T. Caramori, Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University-UNESP, Botucatu, Sao Paulo 18618-970, Braz...</description>
            <author>International Urology and Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663187</comments>
            <pubDate>Thu, 02 Feb 2012 18:17:01 +0100</pubDate>
            <guid isPermaLink="false">5663187</guid>        </item>
        <item>
            <title>Low birth weight and end-stage renal disease: demographic analysis by region in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5663190&amp;cid=c_156597_47_f&amp;fid=35919&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F53u376510t5112r4%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The present study, relating regional distribution between LBW and ESRD dynamics in a nationwide population of Japan, revealed
 that the marked regional differences in the incidence of ESRD within Japan could be explained by a similar regional distribution
 in the incidence of LBW.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s10157-012-0600-zAuthors
		Tadashi Ichikawa, Department of Cardio-Renal Medicine and Hypertension, Nagoya City University, Graduate School of Medical Sciences, Mizuho-ku, Nagoya, 467-8601 JapanMichio Fukuda, Department of Cardio-Renal Medicine and Hypertension, Nagoya City University, Graduate School of Medical Sciences, Mizuho-ku, Nagoya, 467-8601 JapanTamaki Wakamatsu-Yamanaka, Department of Cardio-Renal Me...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Clinical and Experimental Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663190</comments>
            <pubDate>Thu, 02 Feb 2012 18:12:09 +0100</pubDate>
            <guid isPermaLink="false">5663190</guid>        </item>
        <item>
            <title>Sepsis Immunopathology: Perspectives of Monitoring and Modulation of the Immune Disturbances</title>
            <link>http://www.medworm.com/index.php?rid=5666441&amp;cid=c_156597_3_f&amp;fid=33469&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8w21p273g1p4m844%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Septic syndromes are the main cause of death in the intensive care units and although the mortality rates is slowly decreasing,
 the occurrence of the disease has been increasing. The pathogenesis of sepsis includes countless disturbances of the host
 immune system starting with a harmful, infection-triggered exaggerated inflammatory cascade, followed by the development of
 an immunoparalysis state. The latter contributes to the failure in pathogen eradication and leads to secondary infections,
 which are often the cause of fatal complications. In this review, we consider different novel therapeutic strategies for restoration
 of immune function. The use of glucocorticoids, intravenous immunoglobulins, heparin, recombinant human activated protein
 C, granulocyte macroph...</description>
            <author>Archivum Immunologiae et Therapiae Experimentalis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666441</comments>
            <pubDate>Thu, 02 Feb 2012 18:11:05 +0100</pubDate>
            <guid isPermaLink="false">5666441</guid>        </item>
        <item>
            <title>Contemporary Status of Home Dialysis in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5647790&amp;cid=c_156597_10_f&amp;fid=33791&amp;url=http%3A%2F%2Fcontent.karger.com%2Fproduktedb%2Fprodukte.asp%3Fisbn%3D</link>
            <description>ISBN: (Source: Karger Publishers)</description>
            <author>Karger Publishers</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647790</comments>
            <pubDate>Thu, 02 Feb 2012 15:51:22 +0100</pubDate>
            <guid isPermaLink="false">5647790</guid>        </item>
        <item>
            <title>Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis</title>
            <link>http://www.medworm.com/index.php?rid=5667694&amp;cid=c_156597_15_f&amp;fid=33433&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8251h67v83762456%2F</link>
            <description>Conclusions/interpretation&amp;nbsp;&amp;nbsp;Diabetes was a strong predictor of PAD after initiation of haemodialysis therapy in patients with ESRD. In addition, higher
 HbA1c levels were associated with increased risk of developing PAD and requiring limb amputation in such diabetic populations.
 
 
 
 
	Content Type Journal ArticleCategory ArticlePages 1-6DOI 10.1007/s00125-012-2473-9Authors
		H. Ishii, Department of Cardiology, Nagoya University Graduate School of Medicine, 65, Tsurumai-cho, Showa-ku, Nagoya, 466-8550 JapanY. Kumada, Department of Cardiology, Nagoya Kyoritsu Hospital, Nagoya, JapanH. Takahashi, Department of Cardiology, Nagoya Kyoritsu Hospital, Nagoya, JapanT. Toriyama, Department of Cardiology, Nagoya Kyoritsu Hospital, Nagoya, JapanT. Aoyama, Department of Cardiology, Nagoya...</description>
            <author>Diabetologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667694</comments>
            <pubDate>Thu, 02 Feb 2012 06:55:33 +0100</pubDate>
            <guid isPermaLink="false">5667694</guid>        </item>
        <item>
            <title>Baxter Communication: Resumption of  distribution of Monosol solution</title>
            <link>http://www.medworm.com/index.php?rid=5648699&amp;cid=c_156597_13_f&amp;fid=38936&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FNews%2F2012---February%2F02%2FBaxter-Communication-Resumption-of--distribution-of-Monosol-solution%2F</link>
            <description>Source: Baxter Healthcare Ltd
Area: News
 In January 2011, all batches of Monosol, a haemodialysis, haemodiafiltration and haemofiltration solution, were recalled from the market because of a manufacturing problem at the Baxter site in Castlebar, Ireland. In this communication, Baxter Healthcare has announced that the manufacture and distribution of Monosol will resume at the end of January 2012 following a variety of corrective and preventative measures. (Source: NeLM - News)</description>
            <author>NeLM - News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648699</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5648699</guid>        </item>
        <item>
            <title>Renal Replacement Therapy in Cardiology Wards: Changing Trends in a Transitional Country</title>
            <link>http://www.medworm.com/index.php?rid=5649237&amp;cid=c_156597_19_f&amp;fid=29471&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1744-9987.2011.01047.x</link>
            <description>AbstractThe leading causes of death in patients with chronic kidney disease (CKD) are cardiovascular diseases, regardless of the stage of disease or method of renal replacement therapy. On the other hand, CKD is a major risk factor for cardiovascular complications after acute myocardial infarction, as well as for adverse outcome in patients with chronic heart failure. In the present study we prospectively followed‐up nephrological interventions in cardiology wards in order to determine changes in indications, treatment possibilities and outcome of patients. All patients treated at cardiology ward of the Clinical Hospital Centre Zagreb and requiring renal replacement therapy from January 2003 to December 2009 were included in the investigation. Cardiology hospital unit (intensive care or ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Therapeutic Apheresis and Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649237</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649237</guid>        </item>
        <item>
            <title>Geriatric Nutritional Risk Index May Be a Significant Predictor of Mortality in Korean Hemodialysis Patients: A Single Center Study</title>
            <link>http://www.medworm.com/index.php?rid=5649238&amp;cid=c_156597_19_f&amp;fid=29471&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1744-9987.2011.01046.x</link>
            <description>We examined the GNRI of 120 maintenance HD patients and followed these patients for 120 months. Predictors for all‐cause death were examined using life table analysis and the Cox proportional hazards model. Life table analysis revealed that subjects with a GNRI &amp;lt; 90 (n = 19) had a marginally lower survival rate than did those with a GNRI ≥ 90 (n = 101) (Wilcoxon test, P = 0.048). Multivariate Cox proportional hazards analyses demonstrated that the GNRI was a significant predictor of mortality (hazard ratio 0.966, 95% confidence interval 0.945–0.995, P = 0.018), after adjusting for age, sex, presence of diabetes mellitus, and body weight. These results demonstrate that the GNRI may be a significant predictor of mortality in Korean HD patients. (Source: The...</description>
            <author>Therapeutic Apheresis and Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649238</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649238</guid>        </item>
        <item>
            <title>A Model to Predict Optimal Dialysate Flow</title>
            <link>http://www.medworm.com/index.php?rid=5649239&amp;cid=c_156597_19_f&amp;fid=29471&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1744-9987.2011.01040.x</link>
            <description>AbstractDiffusive clearance depends on blood (Qb) and dialysate flow (Qd) rates and the overall mass transfer area coefficient (KoA) of the dialyzer. In this article we describe a model to predict an appropriated AutoFlow (AF) factor (AF factor = Ratio Qd/Qb), that is able to provide adequate Kt/V for hemodialysis patients (HDP), while consuming lower amounts of dialysate, water and energy during the treatment. We studied in vivo the effects of three various Qd on the delivered dose of dialysis in 33 stable HDP. Hemodialysis was performed at Qd of 700 mL/mn, 500 mL/mn, and with AF, whereas specific dialysis prescriptions (treatment time, blood flow rate [Qb], and type and size of dialyzer) were kept constant. The results showed that increasing the dialysate flow rate more than the ...</description>
            <author>Therapeutic Apheresis and Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649239</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649239</guid>        </item>
        <item>
            <title>Cardiovascular Protective Effects of On‐Line Hemodiafiltration: Comparison With Conventional Hemodialysis</title>
            <link>http://www.medworm.com/index.php?rid=5649240&amp;cid=c_156597_19_f&amp;fid=29471&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1744-9987.2011.01042.x</link>
            <description>AbstractAtherosclerotic complications have a significant effect on mortality in patients undergoing hemodialysis (HD) therapy. However, anti‐atherosclerotic and cardioprotective effects of on‐line hemodiafiltration (HDF) remain to be elucidated. We prospectively compared the anti‐atherosclerotic and cardioprotective effects in two randomly divided groups, i.e. on‐line HDF group (n = 13) and conventional HD group (n = 9) for 1 year. Surrogate markers were brachial‐ankle pulse wave velocity (baPWV), intima‐media thickness (IMT) of carotid artery as an atherosclerosis marker, and cardiac functional surrogate markers included left ventricular mass index (LVMI), ejection fraction (EF), and LV diastolic capacity represented as E/A and deceleration time (DT). LVMI in on‐li...</description>
            <author>Therapeutic Apheresis and Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649240</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649240</guid>        </item>
        <item>
            <title>A Computerized Treatment Algorithm Trial to Optimize Mineral Metabolism in ESRD.</title>
            <link>http://www.medworm.com/index.php?rid=5667091&amp;cid=c_156597_47_f&amp;fid=38078&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22300740%26dopt%3DAbstract</link>
            <description>ConclusionsA greater proportion of dialysis patients achieved improved phosphorus but not parathyroid hormone control by switching from a predominantly active vitamin D analogue-based treatment regimen for mineral and bone disorder to a computer-driven algorithm that incorporated cinacalcet and low-dose active vitamin D analogues as first-line therapy.
    PMID: 22300740 [PubMed - as supplied by publisher] (Source: Clinical Journal of the American Society of Nephrology : CJASN)</description>
            <author>Clinical Journal of the American Society of Nephrology : CJASN</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667091</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5667091</guid>        </item>
        <item>
            <title>ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis</title>
            <link>http://www.medworm.com/index.php?rid=5660575&amp;cid=c_156597_19_f&amp;fid=33371&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl2630832458253x6%2F</link>
            <description>This study included
 195 patients on HD for more than 6&amp;nbsp;months. HD patients were allocated into two groups according to the occurrence or not of
 previous episode of VAT; HD with VAT (N&amp;nbsp;=&amp;nbsp;46) and HD without VAT (N&amp;nbsp;=&amp;nbsp;149). ADAMTS13 and VWF were performed by ELISA. There was no significant difference between HD patients with and without
 VAT for ADAMTS13 and VWF levels. However, VWF levels were higher (P&amp;nbsp;&amp;lt;&amp;nbsp;0.001) and ADAMTS13 were lower (P&amp;nbsp;&amp;lt;&amp;nbsp;0.001) in HD patients, comparing to the control group composed by healthy subjects without kidney disease, age and sex-matched
 (N&amp;nbsp;=&amp;nbsp;80). Taken together our data suggest a potential role of the kidneys function compromised on ADAMTS13 synthesis or metabolism,
 regardless other known sources of ...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Journal of Thrombosis and Thrombolysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660575</comments>
            <pubDate>Wed, 01 Feb 2012 17:11:00 +0100</pubDate>
            <guid isPermaLink="false">5660575</guid>        </item>
        <item>
            <title>Left Ventricular End‐Diastolic Diameter is an Independent Predictor of Mortality in Hemodialysis Patients</title>
            <link>http://www.medworm.com/index.php?rid=5649236&amp;cid=c_156597_19_f&amp;fid=29471&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1744-9987.2011.01048.x</link>
            <description>AbstractLeft ventricular (LV) function is impaired in most hemodialysis (HD) patients. We conducted an observational cohort study to investigate whether LV end‐diastolic diameter (LVDd) could predict all‐cause mortality in a cohort of 166 HD patients. The LVDd values (5.06 ± 0.64 cm) of the non‐survivor group were significantly greater than in the survivor group (4.78 ± 0.71 cm). The area under the receiver operating characteristic curve for an LVDd cut‐off value of 5.01 cm was 0.6145 (P = 0.0234). The sensitivity and specificity of the LVDd threshold of 5.01 cm were 75.7% and 50.4%, respectively. The 4‐year survival rate was significantly lower in the group with LVDd ≥ 5.01 cm than in the group with LVDd &amp;lt; 5.01 cm (log‐rank test, P = ...</description>
            <author>Therapeutic Apheresis and Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649236</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649236</guid>        </item>
        <item>
            <title>Chronic kidney disease stressors influence choice of dialysis modality</title>
            <link>http://www.medworm.com/index.php?rid=5650368&amp;cid=c_156597_27_f&amp;fid=32347&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2648.2012.05943.x</link>
            <description>Conclusion.  Pre‐dialysis stress levels predicted dialysis modality. Interventional studies are recommended to address chronic kidney disease stressors with the outcome of improving home‐dialysis usage. (Source: Journal of Advanced Nursing)</description>
            <author>Journal of Advanced Nursing</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5650368</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5650368</guid>        </item>
        <item>
            <title>Does a reduction in dialysate sodium improve blood pressure control in haemodialysis patients?</title>
            <link>http://www.medworm.com/index.php?rid=5654433&amp;cid=c_156597_47_f&amp;fid=32580&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1440-1797.2012.01576.x</link>
            <description>Conclusion:  Change in clinical practice, amounting to a modest reduction in dialysate sodium was associated with a reduction not only in pre and postdialysis blood pressures, but also ultrafiltration requirements and symptomatic intradialytic hypotension. However this effect on blood pressure was most marked for older patients and women, within minimal effects for younger patients, and lesser effects for men, suggesting that dialysate sodium reduction alone may help improve blood pressure control, but requires additional factors such as dietary sodium restriction to be effective in younger male patients.© 2012 The Authors. Nephrology © 2012 Asian Pacific Society of Nephrology (Source: Nephrology)</description>
            <author>Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654433</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5654433</guid>        </item>
        <item>
            <title>The global role of kidney transplantation.</title>
            <link>http://www.medworm.com/index.php?rid=5656652&amp;cid=c_156597_64_f&amp;fid=37277&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22292582%26dopt%3DAbstract</link>
            <description>Authors: Garcia Garcia G, Harden P, Chapman J
    Abstract
    World Kidney Dayon March 8th, 2012 provides a chance to reflect on the success of kidney transplantation as a therapy for end stage kidney disease that surpasses dialysis treatments both for the quality and quantity of life that it provides and for its cost effectiveness. Anything that is both cheaper and better, but is not actually the dominant therapy, must have other drawbacks that prevent replacement of all dialysis treatment by transplantation. The barriers to universal transplantation as the therapy for end stage kidney disease include the economic limitations which, in some countries place transplantation, appropriately, at a lower priority than public health fundamentals such as clean water, sanitation and vaccination. ...</description>
            <author>Archives of Iranian Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5656652</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5656652</guid>        </item>
        <item>
            <title>Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease.</title>
            <link>http://www.medworm.com/index.php?rid=5667231&amp;cid=c_156597_47_f&amp;fid=36075&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22302011%26dopt%3DAbstract</link>
            <description>Conclusions: MMP-2 genotypes or haplotypes modify MMP-2 levels in ESKD patients, and may help to identify patients with increased MMP-2 activity in plasma. Hemodialysis reduces MMP-2 levels independently of MMP-2 genetic variants.
    PMID: 22302011 [PubMed - as supplied by publisher] (Source: American Journal of Nephrology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>American Journal of Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667231</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5667231</guid>        </item>
        <item>
            <title>Imbalanced Matrix Metalloproteinases in Cardiovascular Complications of End‐Stage Kidney Disease: A Potential Pharmacological Target</title>
            <link>http://www.medworm.com/index.php?rid=5667555&amp;cid=c_156597_13_f&amp;fid=37574&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1742-7843.2012.00863.x</link>
            <description>AbstractEnd‐stage kidney disease (ESKD) is a major health problem associated with very high morbidity and mortality secondary to cardiovascular complications, especially in ESKD patients on dialysis. Therefore, exploring key mechanisms underlying cardiovascular alterations associated with ESKD may offer reasonable pharmacological targets that may benefit these patients. Imbalanced matrix metalloproteinases (MMP) activities have been implicated in many cardiovascular diseases, and growing evidence now indicates that excessive MMP activities contribute to cardiovascular complications in ESKD patients. However, there is no study on the effects of MMP inhibitors (MMPIs) in such patients. MMPIs may prevent against the vascular and cardiac changes associated with ESKD. In this MiniReview, we a...</description>
            <author>Basic and Clinical Pharmacology and Toxicology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667555</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5667555</guid>        </item>
        <item>
            <title>Effects of Peripheral Blood Mononuclear Cells Morphology on Vascular Calcification in Uremic Patients on Maintenance Hemodialysis</title>
            <link>http://www.medworm.com/index.php?rid=5668097&amp;cid=c_156597_19_f&amp;fid=29471&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1744-9987.2011.01044.x</link>
            <description>AbstractWe used high‐resolution atomic force microscopy (AFM) to examine possible changes in the morphology of peripheral blood mononuclear cells (PBMCs), and to investigate their influence on vascular calcification in uremic patients on maintenance hemodialysis (MHD). 36 uremic patients had cardiovascular diseases after MHD (MHD group1) and 30 uremic patients did not (MHD group 2), and 20 healthy volunteers were the control group. The extent of coronary artery calcification was assessed with coronary artery calcification score (CACS). AFM was used to analyze PBMCs nuances. Concentrations of bone morphogenetic protein‐2 (BMP‐2) in PBMC supernatants were detected by ELISA. Protein expressions of BMP‐2 were measured by Western blot. No significant differences in PBMC morphology were ...</description>
            <author>Therapeutic Apheresis and Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668097</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5668097</guid>        </item>
        <item>
            <title>Outcomes of living‐donor liver transplantation in patients with preoperative type‐1 hepatorenal syndrome and acute hepatic decompensation</title>
            <link>http://www.medworm.com/index.php?rid=5644051&amp;cid=c_156597_73_f&amp;fid=33600&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Flt.23401</link>
            <description>In conclusion, HRS patients, compared with non‐HRS patients, had worse postoperative renal function and overall survival. However, their five‐year overall survival rate was still nearly 80%, which is satisfactory. Therefore, living‐donor liver transplantation can be considered for patients who have acute hepatic decompensation with or without HRS. © 2012 American Association for the Study of Liver Diseases (Source: Liver Transplantation)</description>
            <author>Liver Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644051</comments>
            <pubDate>Tue, 31 Jan 2012 18:57:13 +0100</pubDate>
            <guid isPermaLink="false">5644051</guid>        </item>
        <item>
            <title>How to manage HIV-infected patients with chronic kidney disease in the HAART era</title>
            <link>http://www.medworm.com/index.php?rid=5663194&amp;cid=c_156597_47_f&amp;fid=35919&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff48g4808477nu441%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;As human immunodeficiency virus (HIV)-infected patients now live longer while receiving highly active antiretroviral therapy
 (HAART), chronic kidney disease (CKD) has emerged as a significant cause of morbidity and mortality among urban HIV population.
 Risk factors associated with CKD in such HIV-infected population include aging, hypertension, diabetes mellitus, co-infection
 with hepatitis&amp;nbsp;C virus, low CD4 cell count, and high HIV viral load. Clinical experience has shown that HIV-infected individuals
 often have one or more concurrent risk factors for CKD. The cumulative effect of multiple risk factors on the development
 of CKD should be noted in this population. Glomerular disease directly related to HIV infection, so-called HIV-associated
 nephropathy, rema...</description>
            <author>Clinical and Experimental Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663194</comments>
            <pubDate>Tue, 31 Jan 2012 16:47:49 +0100</pubDate>
            <guid isPermaLink="false">5663194</guid>        </item>
        <item>
            <title>Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patients</title>
            <link>http://www.medworm.com/index.php?rid=5663189&amp;cid=c_156597_47_f&amp;fid=33391&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff122015w2620801w%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Neutrophil to lymphocyte ratio is a strong predictor for overall and cardiovascular mortality in PD patients.
 
 
 
	Content Type Journal ArticleCategory Nephrology – Original PaperPages 1-8DOI 10.1007/s11255-012-0130-3Authors
		Xin An, Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 People’s Republic of ChinaHai-Ping Mao, Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 People’s Republic of ChinaXin Wei, Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 People’s Republic of ChinaJie-Hui Chen, Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 People’s Republic of...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>International Urology and Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5663189</comments>
            <pubDate>Tue, 31 Jan 2012 07:12:26 +0100</pubDate>
            <guid isPermaLink="false">5663189</guid>        </item>
        <item>
            <title>A Recurrent D‐strand Association Interface is Observed in β‐2 microglobulin Oligomers</title>
            <link>http://www.medworm.com/index.php?rid=5652259&amp;cid=c_156597_39_f&amp;fid=32051&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1742-4658.2012.08510.x</link>
            <description>Summaryβ‐2 microglobulin (β2m) is an amyloidogenic protein responsible for dialysis related amyloidosis in man. In the early stages of amyloid fibril formation, β2m associates into dimers and higher oligomers, but the structural details of such aggregates are poorly understood. To characterize the protein‐protein interactions supporting formation of oligomers, three individual β2m cysteine mutants and their disulphide‐linked homodimers (DIMC20, DIMC50, DIMC60) were prepared. Amyloid propensity, oligomerization state in solution and crystallogenesis were tested for each β2m homodimer: DIMC20 and DIMC50 display a mixture of tetrameric and dimeric species in solution, yield protein crystals and amyloid fibrils, while DIMC60 is dimeric in solution, does not form protein crystals nor...</description>
            <author>FEBS Journal</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652259</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652259</guid>        </item>
        <item>
            <title>Dissecting Aneurysm in A Patient with Autosomal Dominant Polycystic Kidney Disease.</title>
            <link>http://www.medworm.com/index.php?rid=5658928&amp;cid=c_156597_157_f&amp;fid=37523&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22293308%26dopt%3DAbstract</link>
            <description>Authors: Fukunaga N, Yuzaki M, Nasu M, Okada Y
    Abstract
    Autosomal dominant polycystic kidney disease (ADPKD) is primarily associated with renal failure, but it also causes systemic diseases, including cysts of other systemic organs and cerebral or visceral aneurysm. To make matters worse, life-threatening aortic diseases are associated with ADPKD in some cases. However, only a few reports of ADPKD-associated with thoracic aortic dissection have been published. Herein, we present a case of dissecting aneurysm in a patient with hypertension and ADPKD. He had been followed up for type B aortic dissection for six years. Preoperative creatinine level ranged from 2.1 to 2.4 mg/dl. We performed replacement of the thoracic aorta with prosthetic graft successfully, and postoperatively, dial...</description>
            <author>Annals of Thoracic and Cardiovascular Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5658928</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5658928</guid>        </item>
        <item>
            <title>Antioxidant Therapy in Hemodialysis PatientsAntioxidant Therapy in Hemodialysis Patients</title>
            <link>http://www.medworm.com/index.php?rid=5642867&amp;cid=c_156597_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757416%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757416%3Fsrc%3Drss</link>
            <description>How safe are antioxidants for hemodialysis patients? Do they have any impact on oxidative stress and cardiovascular risk factors in this subset of patients?  Kidney International (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642867</comments>
            <pubDate>Mon, 30 Jan 2012 21:46:47 +0100</pubDate>
            <guid isPermaLink="false">5642867</guid>        </item>
        <item>
            <title>P-4-P and Dialysis Centers: Look  Beyond URR P-4-P and Dialysis Centers: Look  Beyond URR</title>
            <link>http://www.medworm.com/index.php?rid=5642572&amp;cid=c_156597_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757433%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757433%3Fsrc%3Drss</link>
            <description>Jeff Berns reviews a study that looked at whether dialysis centers met the urea reduction ratio (URR) metric required for pay-for-performance and suggests better ways for assessing facilities.  Medscape Nephrology (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642572</comments>
            <pubDate>Mon, 30 Jan 2012 17:27:06 +0100</pubDate>
            <guid isPermaLink="false">5642572</guid>        </item>
        <item>
            <title>Infectious Complications of Dialysis Access Devices</title>
            <link>http://www.medworm.com/index.php?rid=5639165&amp;cid=c_156597_20_f&amp;fid=33230&amp;url=http%3A%2F%2Fwww.id.theclinics.com%2Farticle%2FPIIS0891552011000808%2Fabstract%3Frss%3Dyes</link>
            <description>This article reviews the important infectious complications associated with dialysis access, including both hemodialysis and peritoneal dialysis. The discussion highlights the epidemiology, management, and prevention of dialysis access infections. (Source: Infectious Diseases Clinics of North America)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Infectious Diseases Clinics of North America</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639165</comments>
            <pubDate>Sun, 29 Jan 2012 22:43:12 +0100</pubDate>
            <guid isPermaLink="false">5639165</guid>        </item>
        <item>
            <title>Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Chronic Hemodialysis Patient</title>
            <link>http://www.medworm.com/index.php?rid=5638823&amp;cid=c_156597_13_f&amp;fid=37036&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fcrim%2F2012%2F371795%2F</link>
            <description>A 75-year-old male who was undergoing chronic hemodialysis developed abrupt-onset pitting edema and pain in the dorsum of both hands and feet. Biochemical analysis disclosed increased C-reactive protein, and negative rheumatoid factor and antinuclear antibody. Radiological examination showed no bony erosion. Computed tomography and gallium scintigraphy revealed no active infection or neoplasms. The clinical diagnosis was remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome. The pitting edema and inflammatory response quickly subsided after low-dose prednisolone therapy. This case demonstrates that RS3PE syndrome could be a differential diagnosis in elderly patients undergoing dialysis who develop pitting edema and joint pain. (Source: Advances in Pharmacological...</description>
            <author>Advances in Pharmacological Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638823</comments>
            <pubDate>Sun, 29 Jan 2012 18:41:46 +0100</pubDate>
            <guid isPermaLink="false">5638823</guid>        </item>
        <item>
            <title>Successful Utilization of High-Flux Hemodialysis for Treatment of Vancomycin Toxicity in a Child</title>
            <link>http://www.medworm.com/index.php?rid=5638834&amp;cid=c_156597_13_f&amp;fid=37036&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fcrim%2Fpediatrics%2F2011%2F678724%2F</link>
            <description>We report a case of a pediatric patient who developed vancomycin toxicity and associated oliguric renal failure who was treated effectively with high-flux hemodialysis for vancomycin toxicity, clearing serum concentrations of vancomycin by over 75% in only 6 hours (213.2&amp;#x2009;mcg/mL to 51.8&amp;#x2009;mcg/mL) with subsequent return to baseline renal function and without adverse sequelae. While not historically considered a viable option for drug removal in cases of toxicity, new high-flux hemodialysis techniques can remove significant percentages of vancomycin in short periods of time. (Source: Advances in Pharmacological Sciences)</description>
            <author>Advances in Pharmacological Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638834</comments>
            <pubDate>Sun, 29 Jan 2012 18:41:46 +0100</pubDate>
            <guid isPermaLink="false">5638834</guid>        </item>
        <item>
            <title>Dialysate Sodium Concentration and the Association with Interdialytic Weight Gain, Hospitalization, and Mortality</title>
            <link>http://www.medworm.com/index.php?rid=5642270&amp;cid=c_156597_47_f&amp;fid=38806&amp;url=http%3A%2F%2Fwww.nephrologynow.com%2Fpublications%2Fdialysate-sodium-concentration-and-the-association-with-interdialytic-weight-gain-hospitalization-and-mortality</link>
            <description>This analysis of observational DOPPS data examined the impact of reduced dialysate sodium on clinical outcomes.  While lowering dialysate sodium was associated with lower interdialytic weight gain, it was also associated with increased hospitalization.  No mortality benefit was associated with reduced dialysate sodium.
:

Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion
Sodium Bicarbonate for the Prevention of Contrast Induced-Acute Kidney Injury: A Systematic Review and Meta-analysis
Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis (Source: Nephrology Now)</description>
            <author>Nephrology Now</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642270</comments>
            <pubDate>Sat, 28 Jan 2012 08:32:30 +0100</pubDate>
            <guid isPermaLink="false">5642270</guid>        </item>
        <item>
            <title>Decongestive Treatment of Acute Decompensated Heart Failure: Cardiorenal Implications of Ultrafiltration and Diuretics</title>
            <link>http://www.medworm.com/index.php?rid=5642273&amp;cid=c_156597_47_f&amp;fid=38806&amp;url=http%3A%2F%2Fwww.nephrologynow.com%2Fpublications%2Fdecongestive-treatment-of-acute-decompensated-heart-failure-cardiorenal-implications-of-ultrafiltration-and-diuretics</link>
            <description>This review discusses the role of diuretics and ultrafiltration in acute decompensated heart failure.
:

Diuretic Strategies in Patients with Acute Decompensated Heart Failure
Therapeutic Strategies for Heart Failure in Cardiorenal Syndromes
The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis. (Source: Nephrology Now)</description>
            <author>Nephrology Now</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642273</comments>
            <pubDate>Sat, 28 Jan 2012 08:28:56 +0100</pubDate>
            <guid isPermaLink="false">5642273</guid>        </item>
        <item>
            <title>[Case Report] Acute dyspnoea—not always above the diaphragm</title>
            <link>http://www.medworm.com/index.php?rid=5639289&amp;cid=c_156597_22_f&amp;fid=30418&amp;url=http%3A%2F%2Fwww.thelancet.com%2Fjournals%2Flancet%2Farticle%2FPIIS0140-6736%2811%2961652-8%2Ffulltext%3Frss%3Dyes</link>
            <description>In October, 2010, a 55-year-old woman was admitted to our department for investigation of recurrent ascites. She had a medical history of adult polycystic kidney disease with hepatic cysts. 9 months earlier, she had started peritoneal dialysis, which was changed to haemodialysis after 5 months because of poor catheter flows and underdialysis. Subsequently, she developed ascites which required frequent drainage. The fluid was borderline for transudate or exudate with no malignant cells and was initially attributed to peritoneal irritation from her dialysis catheter. (Source: LANCET)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>LANCET</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639289</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5639289</guid>        </item>
        <item>
            <title>Prediction of Graft Patency and Mortality After Distal Revascularization and Interval Ligation for Hemodialysis Access-Related Hand Ischemia</title>
            <link>http://www.medworm.com/index.php?rid=5633167&amp;cid=c_156597_43_f&amp;fid=38546&amp;url=http%3A%2F%2Fwww.jvascsurg.org%2Farticle%2FPIIS0741521411027522%2Fabstract%3Frss%3Dyes</link>
            <description>The goals for management of access-related hand ischemia (ARHI) are to reverse symptoms and salvage the access. Many procedures have been described, but the optimal treatment remains unresolved. In an effort to guide clinical decision making, this study was undertaken to document our outcomes for distal revascularization and interval ligation (DRIL) and identify predictors of bypass patency and patient mortality. (Source: Journal of Vascular Surgery)</description>
            <author>Journal of Vascular Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633167</comments>
            <pubDate>Fri, 27 Jan 2012 11:25:16 +0100</pubDate>
            <guid isPermaLink="false">5633167</guid>        </item>
        <item>
            <title>Balloon angioplasty vs nitinol stent placement in the treatment of venous anastomotic stenoses of hemodialysis grafts after surgical thrombectomy</title>
            <link>http://www.medworm.com/index.php?rid=5633148&amp;cid=c_156597_43_f&amp;fid=38546&amp;url=http%3A%2F%2Fwww.jvascsurg.org%2Farticle%2FPIIS0741521411028862%2Fabstract%3Frss%3Dyes</link>
            <description>In 2010, CPT code 36147 was created and bundles the work of establishing single catheter access with the diagnostic contrast imaging of the dialysis circuit. In 2012, the introductory wording was updated to clarify reporting concerns voiced by the insurance industry and coding groups. (Source: Journal of Vascular Surgery)</description>
            <author>Journal of Vascular Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633148</comments>
            <pubDate>Fri, 27 Jan 2012 11:25:15 +0100</pubDate>
            <guid isPermaLink="false">5633148</guid>        </item>
        <item>
            <title>Arteriovenous Graft Placement in Predialysis Patients: A Potential Catheter-Sparing Strategy</title>
            <link>http://www.medworm.com/index.php?rid=5633149&amp;cid=c_156597_43_f&amp;fid=38546&amp;url=http%3A%2F%2Fwww.jvascsurg.org%2Farticle%2FPIIS0741521411029879%2Fabstract%3Frss%3Dyes</link>
            <description>Arteriovenous grafts placed predialysis have primary failure rates and cumulative survival rates that are similar to grafts placed after starting dialysis therapy.  The fistula first initiative (www.fistulafirst.org) strongly encourages dialysis access via arteriovenous fistulas. Some patients, however, have anatomy more suitable for a graft. In such cases the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) suggests grafts be placed three to six weeks prior to the need for dialysis therapy. It is difficult to predict the onset of time for the need of dialysis in patients not undergoing dialysis. Some surgeons postpone graft creation until after the initiation of hemodialysis reasoning graft placement prior to dialysis therapy may result in diminished time of p...</description>
            <author>Journal of Vascular Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633149</comments>
            <pubDate>Fri, 27 Jan 2012 11:25:15 +0100</pubDate>
            <guid isPermaLink="false">5633149</guid>        </item>
        <item>
            <title>Report from the Editorial Offices</title>
            <link>http://www.medworm.com/index.php?rid=5642197&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F1%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642197</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642197</guid>        </item>
        <item>
            <title>Editorial</title>
            <link>http://www.medworm.com/index.php?rid=5642198&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F4%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642198</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642198</guid>        </item>
        <item>
            <title>Management of patients with membranous nephropathy</title>
            <link>http://www.medworm.com/index.php?rid=5642199&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F6%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642199</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642199</guid>        </item>
        <item>
            <title>Clinical application of calcium modeling in patients with chronic kidney disease</title>
            <link>http://www.medworm.com/index.php?rid=5642200&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F10%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642200</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642200</guid>        </item>
        <item>
            <title>Pneumocystis jiroveci pneumonia in renal transplantation: time to review our practice?</title>
            <link>http://www.medworm.com/index.php?rid=5642201&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F13%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642201</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642201</guid>        </item>
        <item>
            <title>Midkine and the kidney: health and diseases</title>
            <link>http://www.medworm.com/index.php?rid=5642202&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F16%3Frss%3D1</link>
            <description>Midkine (MK; gene name, Mdk), a heparin-binding growth factor, regulates cell growth, cell survival, migration and anti-apoptotic activity in nephrogenesis and development. In the kidney, MK is expressed mainly in proximal tubular epithelial cells and is induced by oxidative stress through the activation of hypoxia-inducible factor-1&amp;alpha;. The pathophysiological roles of MK are diverse, ranging from the occurrence of acute kidney injury (AKI) to progression of chronic kidney disease, often accompanied by hypertension, renal ischemia and diabetic nephropathy. In particular, hypertension has indispensable implications for various vascular diseases, including cardiovascular and renal disorders. Mdk+/+ mice exhibited marked hypertension in renal ablation model compared with Mdk&amp;ndash;/&amp;ndash...</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642202</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642202</guid>        </item>
        <item>
            <title>Fibrosis, regeneration and cancer: what is the link?</title>
            <link>http://www.medworm.com/index.php?rid=5642203&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F21%3Frss%3D1</link>
            <description>Tubulo-interstitial fibrosis constitutes the final common pathway for all pathological conditions that evolve towards chronic kidney disease, and transforming growth factor-&amp;beta;1 plays a key role in this process. Furthermore, neutrophil gelatinase-associated lipocalin appears not only to be a simple marker of renal injury but also an active player in disease progression. We are not yet able to control and modulate this phenomenon. Therefore, a better understanding of fibrogenic molecular mechanisms is necessary to detect possible therapeutic strategies that interfere with fibrosis and then stop the progression of renal disease. The line of research called &amp;lsquo;regenerative medicine&amp;rsquo; works toward this.
According to many authors, the formation of a fibrotic extracellular matrix dis...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642203</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642203</guid>        </item>
        <item>
            <title>Haematuria: the forgotten CKD factor?</title>
            <link>http://www.medworm.com/index.php?rid=5642204&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F28%3Frss%3D1</link>
            <description>Haematuria is a frequent manifestation of glomerular disease. However, nephrologists devote more attention to the monitoring and therapeutic targeting of another key manifestation of glomerular injury, proteinuria. Recent reports have propelled haematuria to the forefront of clinical nephrology. Thus, glomerular macroscopic haematuria is associated with the development of acute kidney injury (AKI) with predominant tubular cell damage and there is increasing evidence for the negative impact of glomerular haematuria-associated AKI on long-term renal function outcome both in the context of IgA nephropathy and in anticoagulated patients. In addition, an epidemiological association between isolated microscopic haematuria in young adults and long-term incidence of end-stage renal disease has bee...</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642204</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642204</guid>        </item>
        <item>
            <title>Medical management of hepatorenal syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5642205&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F34%3Frss%3D1</link>
            <description>Hepatorenal syndrome (HRS) is defined as the occurrence of renal dysfunction in a patient with end-stage liver cirrhosis in the absence of another identifiable cause of renal failure. The prognosis of HRS remains poor, with a median survival without liver transplantation of &amp;lt;6 months. However, understanding the pathogenesis of HRS has led to the introduction of treatments designed to increase renal perfusion and mean arterial blood pressure using vasopressors and albumin, which has led to improvement in renal function in ~50% of patients. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642205</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642205</guid>        </item>
        <item>
            <title>Outcome of the living kidney donor</title>
            <link>http://www.medworm.com/index.php?rid=5642206&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F41%3Frss%3D1</link>
            <description>Renal transplantation from living kidney donors is still relatively marginal in most of the European countries. However, this source of kidney grafts may help to overcome in part the organ donor shortage of cadaveric donors. The living donor strategy implies correct and objective information about donation risks and completely free acceptance of the living candidate of the donation. In this paper, we reviewed the consequences of kidney donation on the living donor health, considering very short term (linked to the surgery), short term (effect of nephrectomy on glomerular filtration rate) and long term (risk of mortality, chronic kidney disease, proteinuria and hypertension) consequences of kidney donation. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642206</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642206</guid>        </item>
        <item>
            <title>Obesity and iron deficiency in chronic kidney disease: the putative role of hepcidin</title>
            <link>http://www.medworm.com/index.php?rid=5642207&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F50%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642207</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642207</guid>        </item>
        <item>
            <title>Uraemic toxins versus volume and water as the major factor that matters with dialysis</title>
            <link>http://www.medworm.com/index.php?rid=5642208&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F58%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642208</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642208</guid>        </item>
        <item>
            <title>The ultimate salt war? Uraemic toxins are all that count in dialysis patients</title>
            <link>http://www.medworm.com/index.php?rid=5642209&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F62%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642209</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642209</guid>        </item>
        <item>
            <title>The ERA-EDTA Working Group on inherited kidney disorders</title>
            <link>http://www.medworm.com/index.php?rid=5642210&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F67%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642210</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642210</guid>        </item>
        <item>
            <title>Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease</title>
            <link>http://www.medworm.com/index.php?rid=5642211&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F70%3Frss%3D1</link>
            <description>Conclusions. MIC-1/GDF15 is a novel independent serum marker of mortality in CKD capable of significantly improving the mortality prediction of other established markers. MIC-1/GDF15 may mediate protein-energy wasting in CKD and represent a novel therapeutic target for this fatal complication. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642211</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642211</guid>        </item>
        <item>
            <title>High-intensity focussed ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=5642212&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F76%3Frss%3D1</link>
            <description>Conclusions.
HIFU treatment may be of help in controlling SHP in selected patients with CKD. Further experience is clearly needed. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642212</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642212</guid>        </item>
        <item>
            <title>Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-{kappa}B-dependent pathway</title>
            <link>http://www.medworm.com/index.php?rid=5642213&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F81%3Frss%3D1</link>
            <description>Conclusions.
Activation of TLR3 on cultured human podocytes induces CD80 expression and phenotypic change via an NF-B-dependent mechanism and is partially blocked by dexamethasone. These studies provide a mechanism by which viral infections may cause proteinuria. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642213</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642213</guid>        </item>
        <item>
            <title>High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling</title>
            <link>http://www.medworm.com/index.php?rid=5642214&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F90%3Frss%3D1</link>
            <description>Conclusion.
PTEN/Akt/mTOR signaling stimulated by high concentration of glucose is regulated by Cx43 overexpression, which unveils part of the molecular mechanism of Cx43 in regulating hyperglycemia-induced hypertrophy. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642214</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642214</guid>        </item>
        <item>
            <title>Quantification of glomerular number and size distribution in normal rat kidneys using magnetic resonance imaging</title>
            <link>http://www.medworm.com/index.php?rid=5642215&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F100%3Frss%3D1</link>
            <description>Conclusions.
MRI provides a new method for measuring these important microanatomical markers of disease risk and leads the way to in vivo analysis of these parameters, including longitudinal studies of animal models of CKD. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642215</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642215</guid>        </item>
        <item>
            <title>Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablation</title>
            <link>http://www.medworm.com/index.php?rid=5642216&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F107%3Frss%3D1</link>
            <description>Conclusions.
These studies dissociated systemic hypertension and proteinuria from the renal lesions in this model. Durable effects of losartan on blood pressure and proteinuria likely represent epigenetic processes. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642216</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642216</guid>        </item>
        <item>
            <title>Left ventricular periostin gene expression is associated with fibrogenesis in experimental renal insufficiency</title>
            <link>http://www.medworm.com/index.php?rid=5642217&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F115%3Frss%3D1</link>
            <description>Conclusions.
Periostin is involved in fibrotic cardiac remodelling in CRI. The re-expression of periostin is localized to the fibrotic and inflammatory lesions and is most likely the consequence of elevated BP. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642217</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642217</guid>        </item>
        <item>
            <title>Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation</title>
            <link>http://www.medworm.com/index.php?rid=5642218&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F122%3Frss%3D1</link>
            <description>Conclusions. We demonstrated that AA combined with Pi increases Ca deposition in rat VSMCs. The role of AA as cofactor in osteoblastic differentiation was demonstrated by phenotypic changes in VSMCs and enhanced bone mineralization key gene expression. These in vitro preliminary data suggest a potential role for AA combined with Pi in worsening VC. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642218</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642218</guid>        </item>
        <item>
            <title>MR measures of renal perfusion, oxygen bioavailability and total renal blood flow in a porcine model: noninvasive regional assessment of renal function</title>
            <link>http://www.medworm.com/index.php?rid=5642219&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F128%3Frss%3D1</link>
            <description>Conclusions.
Our results demonstrate expected changes given the pharmacologically induced changes in renal function. Maintenance of the medullary oxygen bioavailability in low blood flow states may reflect the autoregulation particular to this region of the kidney. The ability to non-invasively measure all three parameters of kidney function in a single MRI examination and to evaluate the relationships between these functional parameters is potentially useful for evaluating the state of the human kidneys in situ in future studies. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642219</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642219</guid>        </item>
        <item>
            <title>Effect of captopril treatment on recuperation from ischemia/reperfusion-induced acute renal injury</title>
            <link>http://www.medworm.com/index.php?rid=5642220&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F136%3Frss%3D1</link>
            <description>Conclusions.
At the acute stage of renal ischemia/reperfusion-induced AKI, ACE inhibition substantially contributed to the amelioration of acute injury by improving renal function, inhibiting systemic and intrarenal angiotensin-II, attenuating intrarenal inflammation and preserving renal tissue structure. Later on, at the post-reperfusion stage, most of the beneficial effects of captopril administration on the recuperating post-ischemic kidney were no longer evident. Concurrently, ACE inhibition exacerbated intrarenal hypoxia and accelerated oxidative stress, indicating that renal adaptation to some consequences of ischemia does require bioavailability of RAS components. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642220</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642220</guid>        </item>
        <item>
            <title>Extended daily on-line high-volume haemodiafiltration in septic multiple organ failure: a well-tolerated and feasible procedure</title>
            <link>http://www.medworm.com/index.php?rid=5642221&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F146%3Frss%3D1</link>
            <description>Conclusions.
Extended daily on-line HDF using maximum convective volume seems to improve the outcome of septic MOF, especially in the early phase. The investigated mode of treatment proved to be feasible, well tolerated and highly cost effective compared to conventional CRRT. At present, this procedure would be applicable at every ICU facility with nephrological support. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642221</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642221</guid>        </item>
        <item>
            <title>Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury</title>
            <link>http://www.medworm.com/index.php?rid=5642222&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F153%3Frss%3D1</link>
            <description>Conclusion.
Intraoperative avoidance of the extremes of anaemia, especially during severe hypotension and avoidance of transfusion in patients with haemoglobin levels &amp;gt;8 g/dL (&amp;gt;5 mmol/L) may help decrease AKI in patients undergoing cardiac surgery and represent targets for future controlled interventions. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642222</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642222</guid>        </item>
        <item>
            <title>Additional role of urine output criterion in defining acute kidney injury</title>
            <link>http://www.medworm.com/index.php?rid=5642223&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F161%3Frss%3D1</link>
            <description>Conclusion.
Although some AKI cases were not identified by the UOCr alone, the UOCr has an additional role in AKI staging, regardless of diuretic use. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642223</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642223</guid>        </item>
        <item>
            <title>Incidence of stroke symptoms among adults with chronic kidney disease: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study</title>
            <link>http://www.medworm.com/index.php?rid=5642224&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F166%3Frss%3D1</link>
            <description>Conclusions.
&amp;nbsp;Reduced eGFR and higher albuminuria levels are associated with an increased risk for incident stroke symptoms. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642224</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642224</guid>        </item>
        <item>
            <title>Protective effects of PPAR{gamma} agonist in acute nephrotic syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5642225&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F174%3Frss%3D1</link>
            <description>Conclusions.
These results show that PPAR agonist has protective effects on podocytes in acute nephrotic syndrome without deleterious effects on fluid homeostasis. PPAR agonist-induced decrease in proteinuria in acute nephrotic syndrome is dependent at least partially on regulation of peroxisome proliferator-response element-sensitive gene expression such as &amp;alpha;-actinin-4 and nephrin and the restoration of podocyte structure. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642225</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642225</guid>        </item>
        <item>
            <title>Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial</title>
            <link>http://www.medworm.com/index.php?rid=5642226&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F182%3Frss%3D1</link>
            <description>Conclusions.
NGAL is a biomarker of existing CKD but did not predict CKD progression. Atorvastatin reduced plasma NGAL but the significance and mechanisms require further investigation. Atorvastatin had no significant effect on cystatin C. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642226</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642226</guid>        </item>
        <item>
            <title>Predictive role of multilocus genetic polymorphisms in cardiovascular disease and inflammation-related genes on chronic kidney disease in Type 2 diabetes--an 8-year prospective cohort analysis of 1163 patients</title>
            <link>http://www.medworm.com/index.php?rid=5642227&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F190%3Frss%3D1</link>
            <description>Conclusions.
In Type 2 diabetes, there are independent and joint effects of multiple genetic variants on risk of CKD. Risk associations with PON1, PON2, CETP, ITGA2 and LTA genetic polymorphisms underline the importance of lipid metabolism, haemostasis and inflammation in the development of CKD in patients with Type 2 diabetes. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642227</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642227</guid>        </item>
        <item>
            <title>Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC)</title>
            <link>http://www.medworm.com/index.php?rid=5642228&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F197%3Frss%3D1</link>
            <description>Conclusion.
We conclude that the MTHFR-coding polymorphism at A1298C is associated with renal decline in African-Americans with hypertensive nephrosclerosis and is supported by a veteran cohort with a primary care diagnosis of hypertension. Further investigation is needed to confirm such findings and to determine what molecular mechanism may contribute to this association. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642228</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642228</guid>        </item>
        <item>
            <title>TRPC6 gene variants in Turkish children with steroid-resistant nephrotic syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5642229&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F205%3Frss%3D1</link>
            <description>Conclusions.
In conclusion, analysis of TRPC6 gene mutations in FSGS will provide new insights into the pathogenesis of nephrotic syndrome. Previous works have emphasized that the patients with only hereditary familial FSGS carried a missense mutation in the TRPC6 gene. Our findings suggest that TRPC6 mutations may also have an important role in the pathogenesis of sporadic SRNS. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642229</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642229</guid>        </item>
        <item>
            <title>The melatonin receptor 1A (MTNR1A) gene is associated with recurrent and idiopathic calcium nephrolithiasis</title>
            <link>http://www.medworm.com/index.php?rid=5642230&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F210%3Frss%3D1</link>
            <description>Conclusion.
The results of this case&amp;ndash;control study indicate a strong association between allelic variants of MTNR1A and recurrent calcium nephrolithiasis. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642230</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642230</guid>        </item>
        <item>
            <title>Uremia induces functional incompetence of bone marrow-derived stromal cells</title>
            <link>http://www.medworm.com/index.php?rid=5642231&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F218%3Frss%3D1</link>
            <description>Conclusion.
These results clearly demonstrate the functional incompetence in MSCs under uremic conditions and may significantly contribute to the disproportionately high risk for CVD in patients with CKD. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642231</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642231</guid>        </item>
        <item>
            <title>Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients</title>
            <link>http://www.medworm.com/index.php?rid=5642232&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F226%3Frss%3D1</link>
            <description>Conclusions.
Considering that sclerostin is an inhibitor of bone formation, the observed positive correlations of serum sclerostin with BMD and bone volume were unexpected. Whether its increase in dialysis patients has direct pathogenetic relevance or is only a secondary phenomenon remains to be seen. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642232</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642232</guid>        </item>
        <item>
            <title>Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment</title>
            <link>http://www.medworm.com/index.php?rid=5642233&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F231%3Frss%3D1</link>
            <description>Conclusion.
SR of nephrotic syndrome can also be observed in membranous nephropathy patients exhibiting chronic renal impairment. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642233</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642233</guid>        </item>
        <item>
            <title>Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy</title>
            <link>http://www.medworm.com/index.php?rid=5642234&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F235%3Frss%3D1</link>
            <description>Conclusions.
Using an approach of widespread ACEI/ARB treatment and targeted IS, 76% of patients can expect to have achieved at least one PR by 5 years. Achievement of remission is the factor most strongly associated with reduced risk of RRT and death. Treatment with IS is associated with significant treatment complications. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642234</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642234</guid>        </item>
        <item>
            <title>Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study</title>
            <link>http://www.medworm.com/index.php?rid=5642235&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F243%3Frss%3D1</link>
            <description>Conclusion.
The novel QUANTA Flash&amp;trade; GBM CIA demonstrated good sensitivity and specificity and had good agreement with other methods. Our data confirm that ~5% of patients with GPS do not have detectable levels of anti-GBM antibodies. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642235</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642235</guid>        </item>
        <item>
            <title>The Oxford classification as a predictor of prognosis in patients with IgA nephropathy</title>
            <link>http://www.medworm.com/index.php?rid=5642236&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F252%3Frss%3D1</link>
            <description>Conclusion.
The pathologic variables of the Oxford classification correlated significantly with other classifications (the WHO classification and the semiquantitative classification). The Oxford classification is a simple method for predicting renal outcome and differentiating between active and chronic lesions. We suggest that the Oxford classification offers an advantage for determining treatment policy for patients with IgAN. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642236</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642236</guid>        </item>
        <item>
            <title>Apoptosis occurs differentially according to glomerular size in diabetic kidney disease</title>
            <link>http://www.medworm.com/index.php?rid=5642237&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F259%3Frss%3D1</link>
            <description>Conclusions.
The numbers of total cells and podocytes in isolated glomeruli were determined using transmission electron microscopy. Akt phosphorylation was significantly decreased in DM-LG, while it was significantly increased in DM-SG (P &amp;lt; 0.05). The ratio of Bax/Bcl-2 protein expression and active fragments of Caspase-3 and phospho-p53 protein expression were significantly increased in DM-LG compared to DM-SG and C-SG (P &amp;lt; 0.001 and P &amp;lt; 0.01, respectively). In contrast, the expression of p27Kip1 and p21Cip1 was significantly increased in DM-SG compared to DM-LG and C-SG (P &amp;lt; 0.05). The numbers of total glomerular cells and podocytes were significantly decreased in DM-LG (P &amp;lt; 0.05). In conclusion, these data show differential expression of Akt activity and apoptosis-related...</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642237</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642237</guid>        </item>
        <item>
            <title>Higher hemoglobin level is associated with subtle declines in renal function and presence of cardiorenal risk factors in early CKD stages</title>
            <link>http://www.medworm.com/index.php?rid=5642238&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F267%3Frss%3D1</link>
            <description>Conclusion.
Hemoglobin concentration may be slightly higher across subtle declines in renal function and the presence of cardiorenal risk factors in early CKD stages. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642238</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642238</guid>        </item>
        <item>
            <title>Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=5642239&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F276%3Frss%3D1</link>
            <description>Conclusions.
The evidence of pharmacists&amp;rsquo; interventions in patients with chronic kidney disease is sparse, of variable quality and with heterogeneous outcomes. On the basis of best available evidence, pharmacists&amp;rsquo; interventions may have a positive impact on outcomes of patients with chronic kidney disease. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642239</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642239</guid>        </item>
        <item>
            <title>Aristolochic acid nephropathy: variation in presentation and prognosis</title>
            <link>http://www.medworm.com/index.php?rid=5642240&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F292%3Frss%3D1</link>
            <description>Conclusions.
AAN has variant phenotypes with distinct prognosis, which is determined by the variable AA medications. With better understanding of toxic and environmental causes for kidney injury, there would be a better chance to uncover the causal factors of cases of &amp;lsquo;CKD without known causes&amp;rsquo; which is crucial for improving the disease outcomes. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642240</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642240</guid>        </item>
        <item>
            <title>Event-related distress in kidney disease patients</title>
            <link>http://www.medworm.com/index.php?rid=5642241&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F299%3Frss%3D1</link>
            <description>Conclusions.
Event-related distress is common in CKD and CKD5 patients. High event-related distress is associated with worse depressive symptoms and greater somatic and emotional symptom burden, even with adjustments for age and gender. The renal practitioner may need to address patients&amp;rsquo; event-related distress in order to provide optimal care. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642241</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642241</guid>        </item>
        <item>
            <title>Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation</title>
            <link>http://www.medworm.com/index.php?rid=5642242&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F304%3Frss%3D1</link>
            <description>Conclusion.
Our data revealed that longer acyl chain length significantly predicts poorer physical function and worsened anemia, and this data supports our proposed mechanism, which may lead to increased understanding of altered carnitine metabolism in hemodialysis patients. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642242</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642242</guid>        </item>
        <item>
            <title>Long-term retinal, renal and cardiovascular outcomes in diabetic chronic kidney disease without proteinuria</title>
            <link>http://www.medworm.com/index.php?rid=5642243&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F310%3Frss%3D1</link>
            <description>Conclusions.
To protect sight, those with proteinuria and DM need regular retinal examinations. Since diabetic CKD patients without proteinuria are more likely to develop overt proteinuria, close follow-up and risk factor management among these patients appear to be more important than among nondiabetic patients with CKD and no proteinuria. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642243</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642243</guid>        </item>
        <item>
            <title>Ankle--brachial index, vascular calcifications and mortality in dialysis patients</title>
            <link>http://www.medworm.com/index.php?rid=5642244&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F318%3Frss%3D1</link>
            <description>Conclusions.
Both low and high ABI were independent predictors of all-cause and cardiovascular mortality. VC in main arteries were associated with an ABI &amp;lt;0.9. VC in peripheral and distal arteries were associated with an ABI &amp;gt;1.3. ABI is a simple and noninvasive method that allows the identification of high cardiovascular risk patients. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642244</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642244</guid>        </item>
        <item>
            <title>Patient stories about their dialysis experience biases others' choices regardless of doctor's advice: an experimental study</title>
            <link>http://www.medworm.com/index.php?rid=5642245&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F325%3Frss%3D1</link>
            <description>Conclusions.
As &amp;lsquo;new&amp;rsquo; patients were making choices based on past patient experience of those already on dialysis, we recommend caution to services using patient stories about dialysis to support those new to the dialysis in delivering support to those who are new to the decision making process for dialysis modality. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642245</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642245</guid>        </item>
        <item>
            <title>Coumarins and survival in incident dialysis patients</title>
            <link>http://www.medworm.com/index.php?rid=5642246&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F332%3Frss%3D1</link>
            <description>Conclusions.
Our data suggest that coumarins might be less harmful than previously anticipated when clearly indicated and closely monitored. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642246</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642246</guid>        </item>
        <item>
            <title>Exploration of the difference in incidence of renal replacement therapy in elderly patients in Flanders and the Netherlands--a comparison of referral policy</title>
            <link>http://www.medworm.com/index.php?rid=5642247&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F338%3Frss%3D1</link>
            <description>Conclusions.
This study suggests that the lower RRT incidence in the Netherlands cannot be explained by a more restrictive referral policy among physicians in the Netherlands. The data suggested that the latter group had a similar or even more liberal attitude to the referral of older patients than physicians in Flanders. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642247</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642247</guid>        </item>
        <item>
            <title>Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study</title>
            <link>http://www.medworm.com/index.php?rid=5642248&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F345%3Frss%3D1</link>
            <description>Conclusions.
Hemodialyzed patients with low or high PTH or increased b-AP had a high fracture risk. BMD by Dual Energy X-ray Absorptiometry (DEXA), especially at the total hip region, was useful to predict any type of incident of fracture for females with low PTH or to discriminate prevalent spine fracture for every patient. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642248</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642248</guid>        </item>
        <item>
            <title>Incidence, complications and risk factors for severe falls in patients on maintenance haemodialysis</title>
            <link>http://www.medworm.com/index.php?rid=5642249&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F352%3Frss%3D1</link>
            <description>Conclusions.
Severe falls were common in MHD patients in this study and resulted in fractures in &amp;gt;50% of the cases. They were associated with ageing, a past history of falls, malnutrition and depression. Although there was a trend towards a lower POMA score in fallers as compared to non-fallers, the POMA score was not an independent predictor of severe falls in this study. These data may help to stratify the patient&amp;rsquo;s risk of falling in order to target programmes to prevent falls in this population. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642249</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642249</guid>        </item>
        <item>
            <title>Disturbed flow in radial-cephalic arteriovenous fistulae for haemodialysis: low and oscillating shear stress locates the sites of stenosis</title>
            <link>http://www.medworm.com/index.php?rid=5642250&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F358%3Frss%3D1</link>
            <description>Conclusions.
Zones of low and oscillatory shear stress were located in the same sites where luminal reduction was documented in previous experimental studies on sites stenosis distribution in AVF. We conclude that even when exposed to high flow rates, there are spot regions along the AVF exposed to athero-prone shear stress that favour vessel stenosis by triggering IH. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642250</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642250</guid>        </item>
        <item>
            <title>Effect of low-GDP bicarbonate-lactate-buffered peritoneal dialysis solutions on plasma levels of adipokines and gut appetite-regulatory peptides. A randomized crossover study</title>
            <link>http://www.medworm.com/index.php?rid=5642251&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F369%3Frss%3D1</link>
            <description>Conclusions.
Use of GDP-free, neutral-pH, bicarbonate&amp;ndash;lactate-buffered PD solutions is associated with higher plasma levels of acylated ghrelin and adiponectin than classic solutions. These findings may contribute to explaining improved appetite scores and overall survival rates reported with the use of so-called biocompatible PD solutions. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642251</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642251</guid>        </item>
        <item>
            <title>Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis</title>
            <link>http://www.medworm.com/index.php?rid=5642252&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F375%3Frss%3D1</link>
            <description>Conclusions.
Dialysis modality (PD versus HD) in an acute unplanned dialysis setting showed, in our population, no significant influence on survival. HD patients had a significantly higher risk of bacteraemia, perhaps due to central venous dialysis catheter. PD seems to be a safe and efficient, at least comparable, alternative to HD in acute unplanned dialysis settings. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642252</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642252</guid>        </item>
        <item>
            <title>Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function</title>
            <link>http://www.medworm.com/index.php?rid=5642253&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F381%3Frss%3D1</link>
            <description>Conclusions.
Empiric treatment with aminoglycoside for peritonitis was not associated with an adverse effect on RRF in PD patients. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642253</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642253</guid>        </item>
        <item>
            <title>Peritoneal dialysis in infants: the experience of the Italian Registry of Paediatric Chronic Dialysis</title>
            <link>http://www.medworm.com/index.php?rid=5642254&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F388%3Frss%3D1</link>
            <description>Conclusions.
Our data confirm that infants on CPD represent a high-risk group; however, our experience demonstrated that growth was acceptable and a large portion was successfully transplanted. Increased efforts should be aimed at optimizing dialysis efficiency and preventing peritonitis. The higher mortality rate in infants was largely caused by comorbidities. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642254</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642254</guid>        </item>
        <item>
            <title>Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?</title>
            <link>http://www.medworm.com/index.php?rid=5642255&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F396%3Frss%3D1</link>
            <description>Conclusion.
In this cross-sectional study, although NTproBNP was associated with residual renal function, cardiac hypertrophy, volume overload and inflammation on simple univariate analysis, on further examination NTproBNP was predominantly affected by factors associated with volume overload, and these results require confirmation in a prospective study. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642255</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642255</guid>        </item>
        <item>
            <title>Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells</title>
            <link>http://www.medworm.com/index.php?rid=5642256&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F402%3Frss%3D1</link>
            <description>Conclusions.
RTRs, CKD patients and ICI-SCCPos have increased MDSC frequencies and MDSC/DC ratios. These changes may impact on cancer immunosurveillance. Therefore, MDSC represent both a potential therapeutic target and prognostic marker in these patients, with respect to the development of SCC and other malignancies. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642256</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642256</guid>        </item>
        <item>
            <title>Sirolimus-based regimen is associated with decreased expression of glomerular vascular endothelial growth factor</title>
            <link>http://www.medworm.com/index.php?rid=5642257&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F411%3Frss%3D1</link>
            <description>Conclusions.
There is emerging evidence that the VEGF system can play either a beneficial or a detrimental role depending on the specific pathologic situations. Therefore, modulating the renal VEGF axis by using an SRL-based regimen may influence the evolution of kidney injury associated with renal transplantation. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642257</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642257</guid>        </item>
        <item>
            <title>Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study</title>
            <link>http://www.medworm.com/index.php?rid=5642258&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F417%3Frss%3D1</link>
            <description>Conclusion.
ACEI/ARB prescription may be suggested as beneficial among multiple medications for reducing mortality in kidney transplant recipients, but its use was not associated with longer graft survival. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642258</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642258</guid>        </item>
        <item>
            <title>Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(R)) in renal transplant recipients</title>
            <link>http://www.medworm.com/index.php?rid=5642259&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F423%3Frss%3D1</link>
            <description>Conclusions.
These data suggest that Pandemrix&amp;reg; does not provide a protective immune response in the majority of kidney transplant recipients. Therefore, for new vaccines, efficacy as well as safety profiles should be evaluated in this subgroup of patients. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642259</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642259</guid>        </item>
        <item>
            <title>Quantifying the benefit of early living-donor renal transplantation with a simulation model of the Dutch renal replacement therapy population</title>
            <link>http://www.medworm.com/index.php?rid=5642260&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F429%3Frss%3D1</link>
            <description>Conclusions.
Efforts to increase early living-donor RTx could potentially substantially increase LE for patients starting RRT, especially in younger patients. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642260</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642260</guid>        </item>
        <item>
            <title>Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies</title>
            <link>http://www.medworm.com/index.php?rid=5642261&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F435%3Frss%3D1</link>
            <description>Conclusions.
Our data suggests that the link between CMV and AR is far less significant than previously thought. Outcome in patients with CMV may be more determined by coexisting conditions like high donor age and delayed graft function. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642261</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642261</guid>        </item>
        <item>
            <title>Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population</title>
            <link>http://www.medworm.com/index.php?rid=5642262&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F443%3Frss%3D1</link>
            <description>Conclusions.
Overall and cardiovascular mortality results are partially reassuring. However, the seemingly elevated mortality rate among the oldest donors requires further study. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642262</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642262</guid>        </item>
        <item>
            <title>Perirenal fluid collections and monoclonal gammopathy</title>
            <link>http://www.medworm.com/index.php?rid=5642263&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F448%3Frss%3D1</link>
            <description>We report here a case with secondary polycythaemia, monoclonal gammopathy of undetermined significance and renal lymphangiectasis revealed by renal failure. Renal failure was probably linked to renal compression by fluid collections. Renal lymphangiectasis is a rare but has already been described in the literature. In addition, its association with a monoclonal paraprotein and polycythaemia seems to be a new clinical entity recently reported in only one patient. (Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642263</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642263</guid>        </item>
        <item>
            <title>Lymphoplasmacytic lymphoma causing light chain cast nephropathy</title>
            <link>http://www.medworm.com/index.php?rid=5642264&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F450%3Frss%3D1</link>
            <description>Plasma cell dyscrasias are frequently associated with kidney disease through the production of monoclonal immunoglobulin but with a diverse set of pathologic renal patterns. While almost all patients with a renal biopsy showing a cast nephropathy have myeloma, kidney involvement associated with pathological immunoglobulin light chains and lymphoma is rare. To our knowledge, this is the first report of a cast nephropathy associated with lymphoplasmacytic lymphoma. We emphasize the relation between light chain deposition and renal dysfunction in this disease with production of light chains. A therapeutic approach that decreases light chain production appears to be warranted in these patients. (Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642264</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642264</guid>        </item>
        <item>
            <title>Drug-induced erythropoiesis and outcome: should we give up the haemoglobin target approach and return to the ratio between erythropoiesis-stimulating agents and haemoglobin?</title>
            <link>http://www.medworm.com/index.php?rid=5642265&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F454%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642265</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642265</guid>        </item>
        <item>
            <title>Reply</title>
            <link>http://www.medworm.com/index.php?rid=5642266&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F454-a%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642266</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642266</guid>        </item>
        <item>
            <title>Risk of urinary tract carcinoma in aristolochic acid nephropathy</title>
            <link>http://www.medworm.com/index.php?rid=5642267&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F456%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642267</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642267</guid>        </item>
        <item>
            <title>We sincerely thank all our subject and section editors for their hard work over the past year.</title>
            <link>http://www.medworm.com/index.php?rid=5642268&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F457%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642268</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642268</guid>        </item>
        <item>
            <title>Announcements</title>
            <link>http://www.medworm.com/index.php?rid=5642269&amp;cid=c_156597_47_f&amp;fid=36078&amp;url=http%3A%2F%2Fndt.oxfordjournals.org%2Fcgi%2Fcontent%2Fshort%2F27%2F1%2F469%3Frss%3D1</link>
            <description>(Source: Nephrology Dialysis Transplantation)</description>
            <author>Nephrology Dialysis Transplantation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642269</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642269</guid>        </item>
        <item>
            <title>[Treatment of chronic kidney disease: Therapeutic strategy.]</title>
            <link>http://www.medworm.com/index.php?rid=5644694&amp;cid=c_156597_22_f&amp;fid=36725&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22285135%26dopt%3DAbstract</link>
            <description>The objectives are to slow the progression of chronic kidney disease (CKD), to take all the cardiovascular risk factors into account, to screen for and treat specific complications and to prepare, if necessary, for renal replacement treatment (transplantation or dialysis). The principal treatment targets are: blood pressure less than 130/80mmHg and proteinuria less than 0.5g/day (ratio of proteinuria/creatinuria &amp;lt;50mg/mmol). The first-line treatment to reach these goals is angiotensin conversion enzyme inhibitors (ACE inhibitors), combined with diet and other life style changes. The periodicity of clinical and laboratory assessments depends on the CKD stage, the speed of disease progression and the need to reassess the impact of therapeutic interventions. Comprehensive multidisciplinary...</description>
            <author>Presse Medicale</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644694</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5644694</guid>        </item>
        <item>
            <title>Treatment of septic shock with continuous HDF using 2 PMMA hemofilters for enhanced intensity.</title>
            <link>http://www.medworm.com/index.php?rid=5658407&amp;cid=c_156597_73_f&amp;fid=37923&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22287204%26dopt%3DAbstract</link>
            <description>Conclusion: Enhanced intensity PMMA-CHDF may improve hemodynamics and survival rate in patients with refractory septic shock.
    PMID: 22287204 [PubMed - as supplied by publisher] (Source: The International Journal of Artificial Organs)</description>
            <author>The International Journal of Artificial Organs</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5658407</comments>
            <pubDate>Fri, 27 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5658407</guid>        </item>
        <item>
            <title>Intracellular Na+ concentration influences short‐term plasticity of glutamate transporter‐mediated currents in neocortical astrocytes</title>
            <link>http://www.medworm.com/index.php?rid=5630534&amp;cid=c_156597_25_f&amp;fid=33630&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fglia.22294</link>
            <description>AbstractFast synaptic transmission requires a rapid clearance of the released neurotransmitter from the extracellular space. Glial glutamate transporters (excitatory amino acid transporters, EAATs) strongly contribute to glutamate removal. In this work, we investigated the paired‐pulse plasticity of synaptically activated, glutamate transporter‐mediated currents (STCs) in cortical layer 2/3 astrocytes. STCs were elicited by local electrical stimulation in layer 4 in the presence of ionotropic glutamate (AMPA and NMDA), GABAA, and GABAB receptor antagonists. In experiments with low [Na+]i (5 mM) intrapipette solution, STCs elicited by paired‐pulse stimulation demonstrated paired‐pulse facilitation (PPF) at short (&amp;lt;250 ms) interstimulus intervals (ISIs) and paired‐pulse depressi...</description>
            <author>Glia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5630534</comments>
            <pubDate>Fri, 27 Jan 2012 01:32:13 +0100</pubDate>
            <guid isPermaLink="false">5630534</guid>        </item>
        <item>
            <title>Parenteral versus oral iron therapy for adults and children with chronic kidney disease.</title>
            <link>http://www.medworm.com/index.php?rid=5627671&amp;cid=c_156597_22_f&amp;fid=38107&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22258974%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The included studies provide strong evidence for increased ferritin and transferrin saturation levels, together with a small increase in haemoglobin, in patients with CKD who were treated with IV iron compared with oral iron. From a limited body of evidence, we identified a significant reduction in ESA requirements in patients treated with IV iron, and found no significant difference in mortality. Adverse effects were reported in only 50% of included studies. We therefore suggest that further studies that focus on patient-centred outcomes are needed to determine if the use of IV iron is justified on the basis of reductions in ESA dose and cost, improvements in patient quality of life, and with few serious adverse effects.
    PMID: 22258974 [PubMed - in process] (Source: Cochr...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Cochrane Database of Systematic Reviews</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5627671</comments>
            <pubDate>Thu, 26 Jan 2012 08:18:08 +0100</pubDate>
            <guid isPermaLink="false">5627671</guid>        </item>
        <item>
            <title>Right intra‐atrial catheter placement for hemodialysis in patients with multiple venous failure</title>
            <link>http://www.medworm.com/index.php?rid=5629850&amp;cid=c_156597_19_f&amp;fid=29463&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1542-4758.2011.00653.x</link>
            <description>AbstractThe purpose of this study is to evaluate the efficacy and safety of direct right atrial catheter insertion for hemodialysis in patients with multiple venous access failure. We retrospectively evaluated the charts of 27 patients with multiple venous access failure who had intra‐atrial dialysis catheter placement between October 2005 and October 2010 in our clinic. Permanent right atrial dialysis catheters were placed through a right anterior mini‐thoracotomy under intratracheal general anesthesia in all patients. Demographics of the cases, the patency rates of hemodialysis via atrial catheterization, existence of any catheter thrombosis, and catheter‐related infections were documented and used in statistical analysis. Seventeen women (63%) and 10 men (37%) with the mean age of...</description>
            <author>Hemodialysis International</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5629850</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5629850</guid>        </item>
        <item>
            <title>Patient and Facility Safety in Hemodialysis: Opportunities and Strategies to Develop a Culture of Safety.</title>
            <link>http://www.medworm.com/index.php?rid=5648718&amp;cid=c_156597_47_f&amp;fid=38078&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22282480%26dopt%3DAbstract</link>
            <description>Authors: Garrick R, Kliger A, Stefanchik B
    Abstract
    Patient safety is the foundation of high-quality health care. More than 350,000 patients receive dialysis in the United States, and the safety of their care is ultimately the responsibility of the facility medical director. The medical director must establish a culture of safety in the dialysis unit and lead the quality assessment and performance improvement process. Several lines of investigation, including surveys of patients and dialysis professionals, have helped to identify important areas of safety risk in dialysis facilities. Among these are lapses in communication, medication errors, patient falls, errors in machine and membrane preparation, failure to follow established policies, and lapses in infection control. The quali...</description>
            <author>Clinical Journal of the American Society of Nephrology : CJASN</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648718</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5648718</guid>        </item>
        <item>
            <title>Methylene diphosphonate-conjugated adriamycin liposomes: preparation, characteristics, and targeted therapy for osteosarcomas in vitro and in vivo.</title>
            <link>http://www.medworm.com/index.php?rid=5659035&amp;cid=c_156597_169_f&amp;fid=37610&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22278099%26dopt%3DAbstract</link>
            <description>Authors: Wu D, Wan M
    Abstract
    Methylenediphosphonate (MDP)-conjugated adriamycin liposomes (MDP-LADMs) were prepared using mild dynamic dialysis equilibrium method, and their targeted therapeutic effects against osteosarcomas and metastatic SOSP-M lung nodules were evaluated in vivo. The drug loading and encapsulation efficiency of the MDP-LADMs were measured via high-performance liquid chromatography, and their size and morphology of the MDP-LADMs were determined using transmission electron microscopy and a particle size analyzer, respectively. Cells apoptosis were evaluated by flow cytometry and caspase-3 activity. The targeted therapeutic effects of MDP-LADMs against UMR106 and SOSP-M osteosarcoma cells were evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliu...</description>
            <author>Biomedical Microdevices</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659035</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659035</guid>        </item>
        <item>
            <title>Mortality Associated with Dose Response of Erythropoiesis-Stimulating Agents in Hemodialysis versus Peritoneal Dialysis Patients.</title>
            <link>http://www.medworm.com/index.php?rid=5667232&amp;cid=c_156597_47_f&amp;fid=36075&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22286821%26dopt%3DAbstract</link>
            <description>Conclusions: Between 2001 and 2006, most PD patients received substantially lower ESA dose for same achieved hemoglobin levels, and low ESA responsiveness was associated with higher mortality in both HD and PD patients.
    PMID: 22286821 [PubMed - as supplied by publisher] (Source: American Journal of Nephrology)</description>
            <author>American Journal of Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5667232</comments>
            <pubDate>Thu, 26 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5667232</guid>        </item>
        <item>
            <title>Mortality Associated with Dose Response of Erythropoiesis-Stimulating Agents in Hemodialysis versus Peritoneal Dialysis Patients</title>
            <link>http://www.medworm.com/index.php?rid=5630502&amp;cid=c_156597_25_f&amp;fid=33500&amp;url=http%3A%2F%2Fcontent.karger.com%2Fproduktedb%2Fprodukte.asp%3Fdoi%3D335685</link>
            <description>Am J Nephrol 2012;35:198–208 (DOI:10.1159/000335685) (Source: American Journal of Nephrology)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>American Journal of Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5630502</comments>
            <pubDate>Wed, 25 Jan 2012 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5630502</guid>        </item>
        <item>
            <title>Adiponectin and Cardiovascular Outcomes among Hemodialysis Patients</title>
            <link>http://www.medworm.com/index.php?rid=5633555&amp;cid=c_156597_47_f&amp;fid=33541&amp;url=http%3A%2F%2Fcontent.karger.com%2Fproduktedb%2Fprodukte.asp%3Fdoi%3D334649</link>
            <description>Kidney Blood Press Res 2012;35:247–253 (DOI:10.1159/000334649) (Source: Kidney and Blood Pressure Research)</description>
            <author>Kidney and Blood Pressure Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633555</comments>
            <pubDate>Wed, 25 Jan 2012 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5633555</guid>        </item>
        <item>
            <title>Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis</title>
            <link>http://www.medworm.com/index.php?rid=5654451&amp;cid=c_156597_47_f&amp;fid=35919&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb71778741x55j736%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Serum cystatin C might be an independent marker of cardiovascular events in incident dialysis patients. Furthermore, eGFRcysC based on measured serum cystatin C could have a new role in predicting cardiovascular events beyond the estimation of true
 GFR.
 
 
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-8DOI 10.1007/s10157-011-0583-1Authors
		Min Ji Shin, Division of Nephrology, Department of Internal Medicine, Pusan National University Hospital School of Medicine, Gudeok-ro 179, Seo-gu, Busan, Republic of KoreaSang Heon Song, Division of Nephrology, Department of Internal Medicine, Pusan National University Hospital School of Medicine, Gudeok-ro 179, Seo-gu, Busan, Republic of KoreaIhm Soo Kwak, Division of Nephrology, Department of Internal Medic...</description>
            <author>Clinical and Experimental Nephrology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654451</comments>
            <pubDate>Wed, 25 Jan 2012 18:13:47 +0100</pubDate>
            <guid isPermaLink="false">5654451</guid>        </item>
        <item>
            <title>News From The Journal Of Clinical Investigation: Jan. 24, 2012</title>
            <link>http://www.medworm.com/index.php?rid=5625943&amp;cid=c_156597_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2Fg4YVFKPY6Zw%2F240717.php</link>
            <description>NEPHROLOGY: Understanding acute kidney injury to identify potential therapeutics Acute kidney injury (AKI) is a life-threatening condition that frequently complicates the care of hospitalized patients. There are no specific therapies to treat AKI other than kidney replacement therapies such as dialysis. Better understanding of the molecular mechanisms underlying AKI is needed if effective new therapies are to be developed... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625943</comments>
            <pubDate>Wed, 25 Jan 2012 09:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625943</guid>        </item>
        <item>
            <title>Therapeutic Plasma Exchange for Renal‐Related Conditions in the Elderly: Ten Years Experience in One Center</title>
            <link>http://www.medworm.com/index.php?rid=5629855&amp;cid=c_156597_19_f&amp;fid=29470&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1525-139X.2011.01027.x</link>
            <description>AbstractThe elderly people, 65 years old and above, are growing in number. The structural and functional changes associated with aging place the elderly at risk when challenged by extracorporeal therapies, such as therapeutic plasma exchange (TPE). We retrospectively analyzed data on all patients who underwent TPE for renal indications at our institution between January 1, 2000 and June 30, 2010 and compared renal indications and mortality associated with the use of TPE in older versus younger patients. During this period, 621 patients underwent 4722 sessions of TPE. Of them, 191 patients were elderly (30.7%) and they underwent 1289 sessions (27.3%) of TPE. A total of 104 patients (16.7%) underwent 593 sessions of TPE because of renal‐related indications: 26 patients in the elderly gro...</description>
            <author>Seminars In Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5629855</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5629855</guid>        </item>
        <item>
            <title>Low‐Density Lipoprotein Apheresis: Principles and Indications</title>
            <link>http://www.medworm.com/index.php?rid=5629856&amp;cid=c_156597_19_f&amp;fid=29470&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1525-139X.2011.01025.x</link>
            <description>AbstractLow‐density lipoprotein (LDL) apheresis describes a group of apheresis techniques that selectively remove apolipoprotein B‐containing lipoproteins producing an acute reduction in LDL‐cholesterol (LDL‐C). Six devices are available for the removal of LDL‐C while sparing other important plasma components. The LDL‐apheresis (LDL‐A) is not routinely used for the treatment of hypercholesterolemia, which usually responds to medical management, but is used to treat familial hypercholesterolemia, an inherited metabolic abnormality resulting in premature death due to progressive coronary artery disease, and to treat patients who fail medical management. The mechanism of action of the available LDL‐A devices, reactions that can occur with these treatments, and the role of this...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Seminars In Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5629856</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5629856</guid>        </item>
        <item>
            <title>Evidence‐Based Review of Therapeutic Plasma Exchange in Neurological Disorders</title>
            <link>http://www.medworm.com/index.php?rid=5629857&amp;cid=c_156597_19_f&amp;fid=29470&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1525-139X.2011.01023.x</link>
            <description>AbstractSeveral neurologic disorders have been treated with therapeutic plasma exchange (TPE). Case reports, case series, and clinical trials have published results regarding the outcomes in such patients. The data gathered have been used to formulate evidence‐based guidelines, which can be used to guide therapy in patients with these neurological disorders. Adequately designed and powered randomized controlled trials have proven the efficacy of TPE in some disease entities, while other diseases are lacking such data. In the latter, decisions for the use of TPE must be made using the limited published data available. In this review, we discuss the published evidence regarding the use of TPE in neurological disorders, focusing on the most recent guidelines published by the American Societ...</description>
            <author>Seminars In Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5629857</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5629857</guid>        </item>
        <item>
            <title>Blood Banking and Transfusion Medicine for the Nephrologist</title>
            <link>http://www.medworm.com/index.php?rid=5629858&amp;cid=c_156597_19_f&amp;fid=29470&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1525-139X.2011.01021.x</link>
            <description>This article will provide an overview of blood component descriptions, patient testing, and blood component options and preparations for therapeutic apheresis procedures. (Source: Seminars In Dialysis)</description>
            <author>Seminars In Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5629858</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5629858</guid>        </item>
        <item>
            <title>Radiation Therapy for Dialysis Access Stenosis: Unfulfilled Promise or False Expectations</title>
            <link>http://www.medworm.com/index.php?rid=5629859&amp;cid=c_156597_19_f&amp;fid=29470&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1525-139X.2011.01006.x</link>
            <description>AbstractHemodialysis vascular access dysfunction is a major cause of morbidity and hospitalization in the hemodialysis population at a cost of well over $1 billion per annum. Venous stenosis (due to venous neointimal hyperplasia [VNH]) is the most common cause of polytetrafluroethylene PTFE) dialysis access graft and arteriovenous fistula (AVF) failure. Despite the magnitude of the clinical problem, however, there are currently no effective therapies for this condition. We and others have previously demonstrated that VNH in PTFE dialysis grafts and AVF is composed of smooth muscle cells/myofibroblasts, endothelial cells within neointimal microvessels, and peri‐graft macrophages. Radiation therapy blocks the proliferation and activation of all these cell types. The current review will d...</description>
            <author>Seminars In Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5629859</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5629859</guid>        </item>
        <item>
            <title>Combining PET biodistribution and equilibrium dialysis assays to assess the free brain concentration and BBB transport of CNS drugs</title>
            <link>http://www.medworm.com/index.php?rid=5630485&amp;cid=c_156597_25_f&amp;fid=32258&amp;url=http%3A%2F%2Ffeeds.nature.com%2F%7Er%2Fjcbfm%2Frss%2Faop%2F%7E3%2FkscTUECg4PA%2Fjcbfm.2012.1</link>
            <description>Authors: Roger N Gunn, Scott G Summerfield, Cristian A Salinas, Kevin D Read, Qi Guo, Graham E Searle, Christine A Parker, Phil Jeffrey
          &amp; Marc Laruelle (Source: Journal of Cerebral Blood Flow)</description>
            <author>Journal of Cerebral Blood Flow</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5630485</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5630485</guid>        </item>
        <item>
            <title>Therapeutic Apheresis in Children: Special Considerations.</title>
            <link>http://www.medworm.com/index.php?rid=5635508&amp;cid=c_156597_47_f&amp;fid=36081&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22277133%26dopt%3DAbstract</link>
            <description>Authors: Goldstein SL
    Abstract
    The provision of therapeutic apheresis to children is a technically challenging procedure, requiring trained personnel and an understanding of the disease processes that leads to the need for apheresis. Most apheresis protocols are derived from studies in adult patients, even though most studies are of limited sample size. The focus of this review is to highlight the disease processes commonly treated with therapeutic apheresis in children, and to address the technical considerations pertinent to the provision of safe and effective apheresis in the pediatric setting.
    PMID: 22277133 [PubMed - as supplied by publisher] (Source: Seminars in Dialysis)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Seminars in Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635508</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5635508</guid>        </item>
        <item>
            <title>Therapeutic Plasma Exchange for Renal-Related Conditions in the Elderly: Ten Years Experience in One Center.</title>
            <link>http://www.medworm.com/index.php?rid=5635509&amp;cid=c_156597_47_f&amp;fid=36081&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22277080%26dopt%3DAbstract</link>
            <description>Authors: Hayes JS, Balogun RA, Chang J, Abdel Rahman EM
    Abstract
    The elderly people, 65 years old and above, are growing in number. The structural and functional changes associated with aging place the elderly at risk when challenged by extracorporeal therapies, such as therapeutic plasma exchange (TPE). We retrospectively analyzed data on all patients who underwent TPE for renal indications at our institution between January 1, 2000 and June 30, 2010 and compared renal indications and mortality associated with the use of TPE in older versus younger patients. During this period, 621 patients underwent 4722 sessions of TPE. Of them, 191 patients were elderly (30.7%) and they underwent 1289 sessions (27.3%) of TPE. A total of 104 patients (16.7%) underwent 593 sessions of TPE becau...</description>
            <author>Seminars in Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635509</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5635509</guid>        </item>
        <item>
            <title>Low-Density Lipoprotein Apheresis: Principles and Indications.</title>
            <link>http://www.medworm.com/index.php?rid=5635510&amp;cid=c_156597_47_f&amp;fid=36081&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22277063%26dopt%3DAbstract</link>
            <description>Authors: Winters JL
    Abstract
    Low-density lipoprotein (LDL) apheresis describes a group of apheresis techniques that selectively remove apolipoprotein B-containing lipoproteins producing an acute reduction in LDL-cholesterol (LDL-C). Six devices are available for the removal of LDL-C while sparing other important plasma components. The LDL-apheresis (LDL-A) is not routinely used for the treatment of hypercholesterolemia, which usually responds to medical management, but is used to treat familial hypercholesterolemia, an inherited metabolic abnormality resulting in premature death due to progressive coronary artery disease, and to treat patients who fail medical management. The mechanism of action of the available LDL-A devices, reactions that can occur with these treatments, and the...</description>
            <author>Seminars in Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635510</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5635510</guid>        </item>
        <item>
            <title>Evidence-Based Review of Therapeutic Plasma Exchange in Neurological Disorders.</title>
            <link>http://www.medworm.com/index.php?rid=5635511&amp;cid=c_156597_47_f&amp;fid=36081&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22277020%26dopt%3DAbstract</link>
            <description>Authors: Chhibber V, Weinstein R
    Abstract
    Several neurologic disorders have been treated with therapeutic plasma exchange (TPE). Case reports, case series, and clinical trials have published results regarding the outcomes in such patients. The data gathered have been used to formulate evidence-based guidelines, which can be used to guide therapy in patients with these neurological disorders. Adequately designed and powered randomized controlled trials have proven the efficacy of TPE in some disease entities, while other diseases are lacking such data. In the latter, decisions for the use of TPE must be made using the limited published data available. In this review, we discuss the published evidence regarding the use of TPE in neurological disorders, focusing on the most recent gui...</description>
            <author>Seminars in Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635511</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5635511</guid>        </item>
        <item>
            <title>Blood Banking and Transfusion Medicine for the Nephrologist.</title>
            <link>http://www.medworm.com/index.php?rid=5635512&amp;cid=c_156597_47_f&amp;fid=36081&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22276991%26dopt%3DAbstract</link>
            <description>This article will provide an overview of blood component descriptions, patient testing, and blood component options and preparations for therapeutic apheresis procedures.
    PMID: 22276991 [PubMed - as supplied by publisher] (Source: Seminars in Dialysis)</description>
            <author>Seminars in Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635512</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5635512</guid>        </item>
        <item>
            <title>Radiation Therapy for Dialysis Access Stenosis: Unfulfilled Promise or False Expectations.</title>
            <link>http://www.medworm.com/index.php?rid=5635513&amp;cid=c_156597_47_f&amp;fid=36081&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22276964%26dopt%3DAbstract</link>
            <description>Authors: Ahmed S, Roy-Chaudhury P
    Abstract
    Hemodialysis vascular access dysfunction is a major cause of morbidity and hospitalization in the hemodialysis population at a cost of well over $1 billion per annum. Venous stenosis (due to venous neointimal hyperplasia [VNH]) is the most common cause of polytetrafluroethylene PTFE) dialysis access graft and arteriovenous fistula (AVF) failure. Despite the magnitude of the clinical problem, however, there are currently no effective therapies for this condition. We and others have previously demonstrated that VNH in PTFE dialysis grafts and AVF is composed of smooth muscle cells/myofibroblasts, endothelial cells within neointimal microvessels, and peri-graft macrophages. Radiation therapy blocks the proliferation and activation of all th...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Seminars in Dialysis</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635513</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5635513</guid>        </item>
        <item>
            <title>Is Conventional Hemodialysis Enough to Manage Carbamazepine Intoxication</title>
            <link>http://www.medworm.com/index.php?rid=5629906&amp;cid=c_156597_19_f&amp;fid=33504&amp;url=http%3A%2F%2Fcontent.karger.com%2Fproduktedb%2Fprodukte.asp%3Fdoi%3D335608</link>
            <description>Blood Purif 2012;33:225–226 (DOI:10.1159/000335608) (Source: Blood Purification)</description>
            <author>Blood Purification</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5629906</comments>
            <pubDate>Tue, 24 Jan 2012 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5629906</guid>        </item>
        <item>
            <title>Children’s and Blue Cross Blue Shield usher in new age of quality-based benchmarks in pediatrics</title>
            <link>http://www.medworm.com/index.php?rid=5631042&amp;cid=c_156597_33_f&amp;fid=39043&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fchildrenshospitalblog%2F%7E3%2F93QQb15m91A%2F</link>
            <description>Sandra Fenwick, president and COO

I’ve worked at Children&amp;#8217;s Hospital Boston for more than a decade, and I’m still inspired every day by the hope and strength I see on the faces of our patients and their families. As Children’s navigates a challenging and evolving health care landscape, I draw on that inspiration and determination, especially when many in our industry seem to imply that cost is the only measure of a hospital’s worth.
At Children’s, our worth—our value—is so much more than just dollars and cents. It means being treated by pediatric experts—doctors, nurses and support staff—who understand that children are not small adults and their care needs to reflect that fact. It’s a commitment to care and innovation that produces programs like our Community As...</description>
            <author>Thrive, Children's Hospital Boston</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5631042</comments>
            <pubDate>Tue, 24 Jan 2012 13:27:29 +0100</pubDate>
            <guid isPermaLink="false">5631042</guid>        </item>
        <item>
            <title>Ipsilateral hemodialysis access after axillary dissection for breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5638097&amp;cid=c_156597_6_f&amp;fid=33460&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk8k1461u1k61l125%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Breast cancer survivors who have had axillary lymph node dissection (ALND) and who later develop end-stage renal failure may
 eventually require hemodialysis access. If veins available for access in the contralateral arm have been exhausted, especially
 after chemotherapy, the ipsilateral arm will have to be considered for access construction. There are no evidence-based guidelines
 for lymphedema prevention, but there are sweeping recommendations to avoid physical injury to the ipsilateral limb, including
 needle puncture, after ALND with or without radiotherapy. Three studies have shown little or no effect of hand surgery in
 producing or exacerbating lymphedema after ALND. Dialysis access guidelines recommend the use of autogenous accesses over
 synthetic grafts when...</description>
            <author>Breast Cancer Research and Treatment</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638097</comments>
            <pubDate>Tue, 24 Jan 2012 07:35:03 +0100</pubDate>
            <guid isPermaLink="false">5638097</guid>        </item>
        <item>
            <title>Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis</title>
            <link>http://www.medworm.com/index.php?rid=5639499&amp;cid=c_156597_25_f&amp;fid=33319&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj53l6653v51129wl%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Restless legs syndrome (RLS) is common in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD). A few studies
 so far have investigated RLS prevalence in ESRD patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The
 aim of this study was to compare the prevalence, characteristics, consequences and predictors of RLS between HD and CAPD patients.
 We recruited 58 HD and 28 CAPD patients. A neurologist expert in sleep medicine performed RLS diagnosis during a face-to-face
 interview. The prevalence of RLS was slightly higher in HD than in CAPD patients (19 vs. 10.7%). RLS appeared after the onset
 of kidney complaint in HD patients; in contrast, in CAPD patients RLS preceded the occurrence of renal disease. Five HD patients
 reported that ...</description>
            <author>Neurological Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639499</comments>
            <pubDate>Tue, 24 Jan 2012 07:34:39 +0100</pubDate>
            <guid isPermaLink="false">5639499</guid>        </item>
    </channel>
</rss>

